Cluster headache, wide

G6_CLUSTHEADACHE_WIDE

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G44.0 Hospital discharge: ICD-9 — 3468X Hospital discharge: ICD-8 — 34601 Cause of death: ICD-10 — G44.0 Cause of death: ICD-9 — 3468X Cause of death: ICD-8 — 34601 2 out of 7 registries used, show all original rules.	1571
4. Check minimum number of events None	1571
5. Include endpoints G6_CLUSTHEADACHE_STRICT	1571
6. Filter based on genotype QC (FinnGen only)	1571

Control definitions (FinnGen only)

Control exclude: G6_EPIPAROX

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF6

NAME	G6_CLUSTHEADACHE_WIDE
CONTROL_EXCLUDE	G6_EPIPAROX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	G6_CLUSTHEADACHE_STRICT
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G440
HD_ICD_9	3468X
HD_ICD_8	34601
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G440
COD_ICD_9	3468X
COD_ICD_8	34601
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cluster headache, wide based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Cluster headache, strict

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	9585	4244	5266
Only index persons	9107	4097	5010
Unadjusted period prevalence (%)
Whole population	0.14	0.12	0.15
Only index persons	0.17	0.15	0.19
Median age at first event (years)
Whole population	41.39	42.50	40.51
Only index persons	40.96	42.12	40.01

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1571	919	652
Unadjusted period prevalence (%)	0.30	0.31	0.29
Median age at first event (years)	44.87	42.98	47.53

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1408: Matched controls
14081

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

32.0

323.0

940

832

C08DA01

ATC

verapamil; systemic

81.6

323.0

622

135

G44.0

ICD-10 Finland

Cluster headache syndrome

16384.0

323.0

1289

R51.80

ICD-10 Finland

Headache

13.2

316.4

634

824

N03AX11

ATC

topiramate; oral

106.5

305.6

328

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

41.3

264.7

334

105

G43.9

ICD-10 Finland

Migraine, unspecified

37.1

246.6

319

110

N02CC03

ATC

zolmitriptan; nasal, oral

20.3

241.2

377

249

G44.2

ICD-10 Finland

Tension-type headache

12.9

224.4

431

464

G47.3

ICD-10 Finland

Sleep apnoea

21.4

201.6

307

181

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

23.9

189.2

277

143

H02AB06

ATC

prednisolone; systemic

4.9

166.4

936

4081

N03AG01

ATC

valproic acid; systemic, rectal

15.3

165.9

287

231

N02CC04

ATC

rizatriptan; oral

13.1

162.9

304

290

G43.3

ICD-10 Finland

Complicated migraine

120.7

159.1

170

N03AX12

ATC

gabapentin; oral

6.9

154.4

445

886

N02CC07

ATC

frovatriptan; oral

16.9

144.3

238

167

3468X

ICD-9 Finland

Migraine, Other forms of migraine

+∞

113.1

107

N02CC06

ATC

eletriptan; oral

16.4

112.7

187

130

3007

Kela drug reimbursment

Erenumab and fremanezumab

157.8

111.0

116

N06CA01

ATC

amitriptyline and psycholeptics; systemic

7.3

108.8

287

480

N06AA09

ATC

amitriptyline; systemic

7.4

106.3

276

450

N03AX16

ATC

pregabalin; oral

4.2

103.6

487

1572

N02AX02

ATC

tramadol; systemic, rectal

3.5

102.4

748

3478

G44.8

ICD-10 Finland

Other specified headache syndromes

67.4

97.4

112

AA1AD

NOMESCO Finland

CT of head and brain

4.3

89.5

393

1165

C09CA06

ATC

candesartan; oral

4.1

89.2

418

1315

A02BC02

ATC

pantoprazole; systemic

3.2

88.2

1006

6166

C07AA05

ATC

propranolol; systemic

3.9

87.2

442

1486

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

3.2

86.5

654

3000

G43.8

ICD-10 Finland

Other migraine

80.2

86.4

N02CD01

ATC

erenumab; parenteral

160.1

86.1

N01

ICPC

Headache

5.4

86.0

290

650

M01AE02

ATC

naproxen; oral, rectal

3.1

84.0

957

5759

N02CC05

ATC

almotriptan; oral

11.2

83.9

165

G43

ICD-10 Finland

Migraine

9.5

81.0

175

208

A03FA01

ATC

metoclopramide; systemic, rectal

3.7

80.8

424

1454

H02AB07

ATC

prednisone; oral

4.4

79.9

329

905

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

6.7

79.1

217

373

M03BX02

ATC

tizanidine; oral

3.0

78.2

1031

6668

R5140

NOMESCO Finland

Monitoring the use of the aid

15.6

77.5

130

N06AX21

ATC

duloxetine; oral

5.2

75.6

260

589

C07AB07

ATC

bisoprolol; oral

3.0

75.6

641

3093

N89

ICPC

Migraine

12.7

74.6

137

118

N03AX09

ATC

lamotrigine; oral

8.7

71.9

163

209

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

5.9

68.9

208

402

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

39.7

68.1

N06AX16

ATC

venlafaxine; oral

4.0

67.0

311

940

N03AF01

ATC

carbamazepine; oral, rectal

9.2

66.9

146

175

R51

ICD-10 Finland

Headache

7.2

65.3

168

261

N02CX04

ATC

16.5

64.9

106

M01AE03

ATC

ketoprofen; systemic, rectal

2.7

64.8

614

3090

N02CC02

ATC

naratriptan; oral

17.9

64.4

102

A02BC05

ATC

esomeprazole; systemic

2.7

63.1

642

3356

M01AG02

ATC

tolfenamic acid; oral, rectal

3.6

62.4

331

1111

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.9

61.3

218

505

N02BE01

ATC

paracetamol; systemic, rectal

3.4

60.6

1245

9711

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.6

60.5

744

4296

N02CD03

ATC

fremanezumab; systemic

134.0

60.4

N90

ICPC

Cluster headache

315.5

59.8

N06AX11

ATC

mirtazapine; oral

2.7

59.3

526

2509

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

5.4

58.8

191

399

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

3.0

58.6

423

1770

M03AX01

ATC

botulinum toxin; parenteral

30.5

58.2

N05BA01

ATC

diazepam; systemic, rectal

4.0

57.1

255

736

M03BC01

ATC

orphenadrine (citrate); systemic

2.9

56.9

450

1988

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

6.7

56.9

152

248

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

54.5

R03AC02

ATC

salbutamol; inhalant

2.4

54.2

814

5102

R07.4

ICD-10 Finland

Chest pain, unspecified

2.9

53.4

404

1724

M79.6

ICD-10 Finland

Pain in limb

2.5

52.2

549

2838

N06AA10

ATC

nortriptyline; systemic

16.4

52.1

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.7

51.0

424

1911

R06.0

ICD-10 Finland

Dyspnoea

2.9

50.1

360

1478

R51.81

ICD-10 Finland

Facial pain NOS

12.1

49.9

A02BC03

ATC

lansoprazole; oral

2.6

49.9

450

2123

J45.9

ICD-10 Finland

Asthma, unspecified

3.2

49.0

298

1089

M54.5

ICD-10 Finland

Low back pain

2.5

48.8

535

2799

M03BX01

ATC

baclofen; systemic

13.6

48.3

M03BC51

ATC

orphenadrine, combinations; systemic

2.5

48.3

490

2461

R42

ICD-10 Finland

Dizziness and giddiness

3.0

46.6

314

1227

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.6

44.6

389

1778

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.3

44.1

249

857

TPH04

NOMESCO Finland

Cathetrisation of vein

2.8

43.7

333

1402

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.0

43.6

286

1094

A02BC01

ATC

omeprazole; systemic

2.5

43.1

406

1934

M01AB05

ATC

diclofenac; systemic, rectal

2.2

42.9

989

7209

J01AA02

ATC

doxycycline; systemic

2.4

42.7

1105

8503

N02CA52

ATC

ergotamine, combinations excl. psycholeptics; oral

16.6

42.1

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

3.6

41.4

209

658

N05AN01

ATC

lithium; oral

7.9

41.3

130

N05BA04

ATC

oxazepam; oral

2.5

41.0

380

1786

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

3.1

40.9

254

930

N05AH04

ATC

quetiapine; oral

2.8

40.6

295

1198

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.2

40.3

560

3219

XF400

NOMESCO Finland

ECG with 12 standard connections

3.1

39.5

243

882

C07AB02

ATC

metoprolol; systemic

3.0

39.3

265

1024

G43.2

ICD-10 Finland

Status migrainosus

108.2

38.9

G44.1

ICD-10 Finland

Vascular headache, not elsewhere classified

+∞

38.7

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.1

38.6

699

4487

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.6

38.4

192

598

WX780

NOMESCO Finland

Remote monitoring CPAP

200.4

38.0

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

5.1

38.0

125

262

N03AE01

ATC

clonazepam; systemic

4.9

37.8

131

290

M25.5

ICD-10 Finland

Pain in joint

2.3

37.8

447

2365

G50.1

ICD-10 Finland

Atypical facial pain

12.2

37.6

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.1

37.5

765

5137

N06AB10

ATC

escitalopram; oral

2.5

37.3

345

1605

A02BA02

ATC

ranitidine; systemic

2.8

37.3

280

1156

M79.0

ICD-10 Finland

Rheumatism, unspecified

7.9

37.0

117

N02AJ06

ATC

codeine and paracetamol; systemic

2.1

37.0

572

3411

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.9

36.7

260

1035

N03AF02

ATC

oxcarbazepine; oral

14.7

36.7

H57.1

ICD-10 Finland

Ocular pain

7.1

36.2

135

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.5

35.6

182

576

N05CF01

ATC

zopiclone; oral

2.2

35.2

441

2380

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

355.7

35.1

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.8

34.7

245

970

M54.9

ICD-10 Finland

Dorsalgia, unspecified

3.2

34.5

202

704

Z01.8

ICD-10 Finland

Other specified special examinations

2.5

34.5

320

1486

R53

ICD-10 Finland

Malaise and fatigue

2.5

34.3

302

1362

N06AB04

ATC

citalopram; systemic

2.4

34.1

335

1602

M01AH05

ATC

etoricoxib; oral

2.0

33.6

856

6157

J01FA06

ATC

roxithromycin; oral

2.0

33.6

584

3617

34601

ICD-8 Finland

Migraine, Morbus Harris-Horton

+∞

33.5

G40.9

ICD-10 Finland

Epilepsy, unspecified

92.3

32.9

M01AB01

ATC

indometacin; systemic, rectal

4.1

32.8

135

354

G50.0

ICD-10 Finland

Trigeminal neuralgia

10.4

32.3

M54.4

ICD-10 Finland

Lumbago with sciatica

2.6

31.7

266

1163

R03DC03

ATC

montelukast; oral

2.6

31.3

263

1147

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

7.6

31.3

104

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

31.3

403

2180

N02CA01

ATC

dihydroergotamine; nasal, systemic

71.6

31.0

R02

ICPC

Shortness of breath/dyspnoea

3.2

30.9

177

604

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

3.3

30.7

167

551

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

10.1

30.3

K07.60

ICD-10 Finland

Snapping jaw

4.4

30.3

115

279

M54.2

ICD-10 Finland

Cervicalgia

3.7

30.3

141

412

R07.3

ICD-10 Finland

Other chest pain

3.5

30.0

151

470

L03

ICPC

Low back symptom/complaint

2.2

29.9

352

1821

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.6

29.9

144

432

M79.1

ICD-10 Finland

Myalgia

2.8

29.9

220

887

XA800

NOMESCO Finland

Neuropsychological investigation

5.8

29.4

157

J01DA01

ATC

[U] cefalexin; systemic

1.9

29.4

885

6613

M79.7

ICD-10 Finland

Fibromyalgia

6.5

29.3

126

J01DB01

ATC

cefalexin; oral

2.1

29.2

1150

9512

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.9

29.2

708

4892

TAB00

NOMESCO Finland

Lumbar puncture

4.7

28.7

102

232

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.5

28.6

258

1167

N02AA05

ATC

oxycodone; systemic

2.9

28.5

193

739

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

4.2

28.5

112

281

R06AE07

ATC

cetirizine; oral

1.9

28.5

635

4241

R01AD09

ATC

mometasone; nasal

1.9

28.5

649

4371

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

3.4

28.3

147

468

J01FA10

ATC

azithromycin; systemic

1.9

28.2

848

6284

N02CD02

ATC

galcanezumab; parenteral

+∞

28.2

D01

ICPC

Abdominal pain/cramps general

3.0

28.2

179

657

R01BA52

ATC

pseudoephedrine, combinations; oral

2.0

27.2

451

2686

H02AB04

ATC

methylprednisolone; systemic

2.6

27.1

223

958

F45.8

ICD-10 Finland

Other somatoform disorders

3.3

27.0

144

468

R03BB04

ATC

tiotropium bromide; inhalant

3.4

26.7

136

426

R4110

NOMESCO Finland

Physiotherapy

2.1

26.6

372

2065

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

3.4

26.5

136

429

R52.2

ICD-10 Finland

Other chronic pain

6.2

26.4

124

P01AB01

ATC

metronidazole; oral, rectal

1.9

26.4

561

3654

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.4

26.4

251

1163

WX110

NOMESCO Finland

Local anesthesy

1.9

26.1

982

7758

R05

ICPC

Cough

2.2

26.1

309

1592

WX723

NOMESCO Finland

CPAP therapy

61.2

26.0

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

26.0

570

3743

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

3.3

26.0

141

463

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

6.6

25.8

105

L01

ICPC

Neck symptom/complaint

2.6

25.6

208

884

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.3

25.5

269

1311

H53.1

ICD-10 Finland

Subjective visual disturbances

4.1

25.3

102

262

A01

ICPC

Pain general/multiple sites

3.5

25.2

122

367

R01AD08

ATC

fluticasone; nasal

2.0

25.2

419

2481

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.7

24.8

115

334

R06.5

ICD-10 Finland

Mouth breathing

3.8

24.5

108

301

H01

ICPC

Ear pain/earache

2.8

24.4

172

671

R52.9

ICD-10 Finland

Pain, unspecified

3.2

24.4

138

467

J02AC01

ATC

fluconazole; systemic

1.8

24.3

574

3845

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.8

24.2

787

5848

A04

ICPC

Weakness/tiredness general

2.6

24.1

188

782

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.3

23.8

249

1205

N06AB03

ATC

fluoxetine; oral

2.6

23.5

186

776

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.1

23.4

135

464

M70.6

ICD-10 Finland

Trochanteric bursitis

2.8

23.2

156

593

J01FA09

ATC

clarithromycin; systemic

1.9

23.0

460

2895

XF402

NOMESCO Finland

ECG with work load test

2.9

22.8

150

562

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.9

22.8

418

2551

R05

ICD-10 Finland

Cough

2.2

22.5

259

1307

R20.2

ICD-10 Finland

Paraesthesia of skin

3.4

22.5

116

367

N06AX12

ATC

bupropion; oral

3.4

22.4

115

363

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

22.3

994

8052

G44

ICD-10 Finland

Other headache syndromes

24.3

22.2

M01AC06

ATC

meloxicam; systemic, rectal

1.8

22.2

469

3000

J01MA02

ATC

ciprofloxacin; systemic

1.8

22.2

486

3150

K30

ICD-10 Finland

Functional dyspepsia

2.7

22.2

160

634

J01FF01

ATC

clindamycin; systemic

1.9

21.7

373

2215

M01AH01

ATC

celecoxib; oral (coxibs)

2.2

21.7

239

1180

A06AC01

ATC

ispaghula (psylla seeds); oral

2.1

21.7

293

1585

M35.7

ICD-10 Finland

Hypermobility syndrome

8.9

21.7

N06AX26

ATC

vortioxetine; oral

3.3

21.7

112

355

M01AE01

ATC

ibuprofen; systemic, rectal

2.3

21.7

1280

11428

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.7

21.3

278

J01CA04

ATC

amoxicillin; systemic

1.9

21.2

1126

9565

UJF32

NOMESCO Finland

Coloscopy

2.0

21.2

314

1758

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.5

21.2

184

809

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.7

21.1

153

604

D06

ICPC

Abdominal pain localized other

2.9

21.1

134

488

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.0

21.0

325

1853

M48.0

ICD-10 Finland

Spinal stenosis

2.9

21.0

136

504

3AX01

NOMESCO Finland

28.5

21.0

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

20.9

R03BA05

ATC

fluticasone; inhalant

2.1

20.8

256

1326

Z71.8

ICD-10 Finland

Other specified counselling

2.0

20.8

329

1890

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.9

20.8

136

505

J45.1

ICD-10 Finland

Nonallergic asthma

3.5

20.7

102

311

D11

ICPC

Diarrhoea

2.4

20.7

186

832

N03AX15

ATC

zonisamide; oral

213.0

20.6

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.8

20.6

139

526

H53.2

ICD-10 Finland

Diplopia

5.7

20.4

107

R21

ICPC

Throat symptom/complaint

2.0

20.3

313

1780

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

4.2

20.2

198

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

8.8

20.2

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.2

20.0

126

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

7.1

20.0

SPAT1060

SPAT

Administration of oxygen

36.3

19.9

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.2

19.8

225

1125

WX002

NOMESCO Finland

Sedation and analgesia

2.1

19.8

257

1362

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.5

19.8

168

729

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

15.6

19.8

R01AD12

ATC

fluticasone furoate; nasal

1.8

19.8

431

2766

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

2.0

19.7

310

1774

A11

ICPC

Chest pain NOS

3.2

19.7

105

341

R55

ICD-10 Finland

Syncope and collapse

2.8

19.4

129

485

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

3.7

19.4

252

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

4.7

19.4

149

WX290

NOMESCO Finland

Other blockade of nerve

1.7

19.3

660

4843

M54.6

ICD-10 Finland

Pain in thoracic spine

3.1

19.2

112

387

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

4.6

19.1

151

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.2

19.1

103

337

G54.0

ICD-10 Finland

Brachial plexus disorders

5.3

19.1

116

N06AB06

ATC

sertraline; oral

2.4

19.1

171

762

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.6

19.0

145

593

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

4.9

18.8

131

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

+∞

18.8

Z00.0

ICD-10 Finland

General medical examination

2.1

18.7

249

1328

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

18.6

475

3187

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.7

18.6

229

R05FB02

ATC

cough suppressants and expectorants

1.7

18.6

460

3060

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.4

18.6

277

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

4.3

18.5

170

E66.01

ICD-10 Finland

Obesity due to excess calories

3.0

18.4

112

399

N05AB04

ATC

prochlorperazine; systemic, rectal

6.6

18.4

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.7

18.3

227

R03AC03

ATC

terbutaline; inhalant

2.2

18.3

206

1025

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

4.5

18.3

149

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

3.3

18.2

303

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

18.1

257

1407

SAA04

NOMESCO Finland

Special inverstigation of mouth

3.2

18.0

312

R50.9

ICD-10 Finland

Fever, unspecified

2.2

18.0

190

916

H04.10

ICD-10 Finland

Dry eye syndrome

2.6

17.9

139

574

P03

ICPC

Feeling depressed

2.6

17.8

138

570

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

+∞

17.7

ZXA10

NOMESCO Finland

Bilateral

2.1

17.7

232

1227

S06.0

ICD-10 Finland

Concussion

2.5

17.6

143

604

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.7

17.6

130

520

ZX114

NOMESCO Finland

Intramuscular

7.7

17.4

N05CF02

ATC

zolpidem; oral

2.0

17.4

243

1319

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.8

17.3

378

2406

N05BA12

ATC

alprazolam; oral

2.5

17.1

145

627

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

31.9

17.1

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

11.7

17.1

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

17.0

431

2872

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

3.5

17.0

247

X58

ICD-10 Finland

Exposure to other specified factors

2.1

17.0

205

1048

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.6

16.8

714

5479

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

16.8

531

3763

G44.4

ICD-10 Finland

Drug-induced headache, not elsewhere classified

64.1

16.8

P76

ICPC

Depressive disorder

2.9

16.8

105

379

34609

ICD-8 Finland

Migraine, Unspecified

+∞

16.7

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

16.7

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.2

16.7

182

891

R11

ICD-10 Finland

Nausea and vomiting

2.8

16.7

110

412

N17

ICPC

Vertigo/dizziness

2.5

16.5

133

559

R03BA01

ATC

beclometasone; inhalant

2.2

16.5

187

931

M02AA07

ATC

piroxicam; topical

1.7

16.4

431

2893

R03BA02

ATC

budesonide; inhalant

2.0

16.2

229

1247

A06AD11

ATC

lactulose; oral

2.3

16.2

153

700

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.1

16.1

306

TDM10

NOMESCO Finland

Puncture of maxillary antrum

3.6

15.9

206

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

15.8

244

1372

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

15.8

169

817

P01

ICPC

Feeling anxious/nervous/tense

2.3

15.8

162

768

J01.1

ICD-10 Finland

Acute frontal sinusitis

6.6

15.7

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.1

15.7

190

972

R74

ICPC

Upper respiratory infection acute

1.7

15.7

408

2729

3460A

ICD-9 Finland

Migraine, Classical migraine

+∞

15.6

M01AH02

ATC

rofecoxib; oral

2.3

15.6

153

710

R03AK07

ATC

formoterol and budesonide; inhalant

1.9

15.5

259

1500

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

15.4

291

1758

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

15.4

386

2548

L28

ICPC

Limited function/disability (L)

2.3

15.4

153

717

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

8.1

15.3

K02.1

ICD-10 Finland

Caries of dentine

1.6

15.1

782

6237

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.5

15.1

127

547

G04CA02

ATC

tamsulosin; oral

2.0

15.1

207

1114

N06AA12

ATC

doxepin; systemic

3.4

15.0

227

S18

ICPC

Laceration/cut

1.6

15.0

495

3521

N04BC05

ATC

pramipexole; oral

2.9

15.0

330

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

6.6

15.0

J45

ICD-10 Finland

Asthma

2.4

14.9

131

574

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.8

14.9

372

B02AA02

ATC

tranexamic acid; systemic

2.0

14.8

205

1104

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

14.8

156

751

SBB10

NOMESCO Finland

Teeth copy

2.9

14.7

344

N03AX14

ATC

levetiracetam; systemic

9.8

14.7

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

3.1

14.6

271

R01AD01

ATC

beclometasone; nasal

2.0

14.5

216

1196

P06

ICPC

Sleep disturbance

2.5

14.5

118

499

C01CA24

ATC

epinephrine; parenteral

2.7

14.5

104

410

E66.8

ICD-10 Finland

Other obesity

3.5

14.4

202

SPAT1254

SPAT

Administration of medicine

2.1

14.3

172

876

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

27.5

14.3

WX892

NOMESCO Finland

Monitored bed care

2.7

14.3

371

R06AX27

ATC

desloratadine; oral

1.7

14.3

377

2518

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.0

14.3

199

1075

SPAT1263

SPAT

Sampling

1.6

14.2

523

3811

R07.0

ICD-10 Finland

Pain in throat

2.9

14.2

317

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

4.3

14.2

124

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.2

14.1

155

758

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

4.2

14.0

130

B01AC04

ATC

clopidogrel; oral

2.3

14.0

138

640

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.7

14.0

362

2400

KMAK

NOMESCO Finland

1.5

14.0

713

5619

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.1

13.9

158

784

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

3.4

13.9

203

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

24.0

13.8

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

13.8

268

1631

J46

ICD-10 Finland

Status asthmaticus

4.7

13.8

100

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.2

13.6

239

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.9

13.6

295

SPAT1104

SPAT

Monitoring of emergency patient

2.9

13.6

302

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

8.0

13.6

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

13.6

3461A

ICD-9 Finland

Migraine, Common migraine

+∞

13.6

A01AB09

ATC

miconazole; local oral

2.4

13.5

117

511

M89.0

ICD-10 Finland

Algoneurodystrophy

9.5

13.5

WX722

NOMESCO Finland

PEEP

7.5

13.5

D02

ICPC

Abdominal pain epigastric

2.8

13.5

322

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

5.1

13.4

XF600

NOMESCO Finland

Bloodpressure measurement

2.9

13.4

300

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

18.4

13.4

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.3

13.4

127

582

N06AX03

ATC

mianserin; oral

3.2

13.4

226

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.2

13.3

148

728

N30.0

ICD-10 Finland

Acute cystitis

2.1

13.3

165

852

J01MA14

ATC

moxifloxacin; systemic

2.4

13.3

115

502

F32.1

ICD-10 Finland

Moderate depressive episode

2.8

13.2

337

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

7.6

13.2

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.7

13.2

338

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

2.0

13.2

174

921

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

2.3

13.2

125

571

C10AA05

ATC

atorvastatin; oral

1.7

13.2

365

2461

C07AB03

ATC

atenolol; systemic

3.3

13.1

201

K08.80

ICD-10 Finland

Toothache NOS

2.3

13.1

120

539

M01AX17

ATC

nimesulide; oral

1.8

13.1

273

1692

L02

ICPC

Back symptom/complaint

2.2

13.1

132

619

A03CA02

ATC

clidinium and psycholeptics; oral

3.0

13.1

269

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.7

13.1

321

2093

N05CD07

ATC

temazepam; oral

2.3

13.1

127

586

C03CA01

ATC

furosemide; systemic

1.9

13.0

224

1306

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

3.1

13.0

236

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.1

13.0

242

B01AB05

ATC

enoxaparin; parenteral

1.7

13.0

334

2203

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

16.9

13.0

Z50.1

ICD-10 Finland

Other physical therapy

3.0

12.9

253

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

4.2

12.9

121

G90.2

ICD-10 Finland

Horner syndrome

22.8

12.9

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.5

12.9

407

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

12.8

137

663

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

6.3

12.8

SPAT1301

SPAT

No procedures

1.6

12.8

360

2437

K59.09

ICD-10 Finland

Constipation, unspecified

3.1

12.7

234

L17

ICPC

Foot/toe symptom/complaint

1.7

12.7

285

1806

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

4.3

12.7

109

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

12.7

773

6285

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

12.6

133

638

R52.1

ICD-10 Finland

Chronic intractable pain

9.4

12.5

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

2.0

12.5

157

815

SGA01

NOMESCO Finland

Tooth opening as first aid

1.8

12.4

230

1374

J01DA06

ATC

[U] cefuroxime; systemic

1.9

12.4

199

1129

R01AD05

ATC

budesonide; nasal

2.4

12.4

112

499

R10.0

ICD-10 Finland

Acute abdomen

3.6

12.4

162

J01CA08

ATC

pivmecillinam; oral

1.6

12.4

469

3417

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.2

12.4

112

C07AB12

ATC

nebivolol; oral

4.2

12.4

112

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.5

12.3

173

F43.1

ICD-10 Finland

Post-traumatic stress disorder

4.0

12.3

122

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

12.3

165

875

M54.1

ICD-10 Finland

Radiculopathy

3.4

12.2

175

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

6.2

12.1

L86

ICPC

Back syndrome with radiating pain

3.0

12.1

248

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

12.1

537

4058

K04.0

ICD-10 Finland

Pulpitis

2.1

12.0

145

739

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

12.0

319

2117

F51.0

ICD-10 Finland

Nonorganic insomnia

1.9

12.0

178

981

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.1

12.0

136

675

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

2.0

12.0

155

813

K80

ICPC

Cardiac arrhythmia NOS

2.7

12.0

315

K10.3

ICD-10 Finland

Alveolitis of jaws

2.8

12.0

274

SPAT1240

SPAT

Therapeutic discussion

2.0

11.9

150

776

WZA90

NOMESCO Finland

Other doctors statement

1.7

11.9

292

1896

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

11.9

343

2331

G81.9

ICD-10 Finland

Hemiplegia, unspecified

8.0

11.9

ZXA05

NOMESCO Finland

Left side

1.7

11.8

287

1856

J01EA01

ATC

trimethoprim; systemic

1.7

11.8

287

1856

R09

ICPC

Sinus symptom/complaint

2.3

11.8

112

514

SPAT1097

SPAT

Recording of ECG

2.0

11.8

157

830

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

11.8

335

2266

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

5.0

11.8

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

11.7

507

3795

A03

ICPC

Fever

1.8

11.7

222

1333

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

2.1

11.7

132

656

G45.4

ICD-10 Finland

Transient global amnesia

30.3

11.7

N07CA01

ATC

betahistine; oral

2.6

11.6

333

H92.0

ICD-10 Finland

Otalgia

2.8

11.6

267

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

2.3

11.6

108

491

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

11.6

270

1727

XA420

NOMESCO Finland

Extensive sleep examination

19.1

11.6

XG466

NOMESCO Finland

Sleep oxymetry

6.6

11.6

AA1AA

NOMESCO Finland

Head X-ray examination

11.2

11.5

A02BC04

ATC

rabeprazole; oral

2.3

11.5

112

519

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

11.5

483

3589

M54.3

ICD-10 Finland

Sciatica

2.7

11.5

312

G44.3

ICD-10 Finland

Chronic post-traumatic headache

121.0

11.4

N06AX22

ATC

agomelatine; oral

4.7

11.4

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.8

11.4

207

1226

XQ800

NOMESCO Finland

Prick test

2.3

11.4

108

492

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

5.3

11.4

R96

ICPC

Asthma

2.3

11.4

108

493

Z01.2

ICD-10 Finland

Dental examination

1.5

11.4

535

4076

S01EC01

ATC

acetazolamide; systemic

5.6

11.4

M01AB55

ATC

diclofenac, combinations; oral

2.6

11.3

315

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.2

11.3

191

T78.4

ICD-10 Finland

Allergy, unspecified

2.9

11.3

231

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.6

11.2

320

I20.09

ICD-10 Finland

Unstable angina

3.2

11.2

192

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.6

11.2

317

2139

H03AA01

ATC

levothyroxine sodium; systemic

1.7

11.2

257

1636

A28

ICPC

Limited function/disability NOS

2.2

11.2

119

575

J20

ICD-10 Finland

Acute bronchitis

2.2

11.1

118

568

DFF00

NOMESCO Finland

Pure tone audiometry

2.3

11.1

102

462

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

2.2

11.0

111

523

ZXA00

NOMESCO Finland

Right side

1.6

11.0

286

1886

J01MA12

ATC

levofloxacin; systemic

1.8

10.9

201

1196

N05AA02

ATC

levomepromazine; systemic

3.0

10.9

211

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.9

10.9

162

896

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

12.0

10.8

UKC02

NOMESCO Finland

Cystoscopy

2.0

10.8

152

821

S22.3

ICD-10 Finland

Fracture of rib

2.5

10.8

334

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

10.8

540

4158

L08

ICPC

Shoulder symptom/complaint

1.8

10.8

208

1256

R4120

NOMESCO Finland

Occupational therapy

2.4

10.8

374

K07.69

ICD-10 Finland

Dislocation of the jaw joint UNS

5.4

10.8

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.9

10.7

221

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

2.3

10.7

101

461

SPAT1058

SPAT

PEF monitoring instruction

2.3

10.7

429

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

4.3

10.6

L12

ICPC

Hand/finger symptom/complaint

1.8

10.6

181

1052

N05AH03

ATC

olanzapine; systemic

2.3

10.5

412

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

10.5

126

641

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.1

10.5

115

563

N06AA06

ATC

trimipramine; systemic

4.1

10.5

SPAT1377

SPAT

Polysomnography

4.5

10.5

N02AJ13

ATC

tramadol and paracetamol; systemic

4.7

10.5

R06AX22

ATC

ebastine; oral

1.7

10.4

232

1461

M54

ICD-10 Finland

Dorsalgia

2.0

10.4

143

765

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.4

10.4

356

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

2.0

10.4

137

724

R03BA08

ATC

ciclesonide; inhalant

2.2

10.4

102

476

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.6

10.3

287

M50.3

ICD-10 Finland

Other cervical disc degeneration

4.0

10.3

102

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.6

10.3

294

J02AC02

ATC

itraconazole; systemic

1.7

10.3

220

1367

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.4

10.3

382

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.6

10.3

327

2266

CA1CG

NOMESCO Finland

Eye and orbita extensive MRI examination with high intensity magnet

8.9

10.3

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.9

10.3

168

960

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

10.3

128

662

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

10.2

304

2068

A02BA04

ATC

nizatidine; systemic

2.4

10.2

386

R60.9

ICD-10 Finland

Oedema, unspecified

3.2

10.2

172

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.4

10.2

387

XF404

NOMESCO Finland

Ambulatory ECG

2.2

10.0

102

483

T82

ICPC

Obesity

3.5

10.0

136

L05

ICPC

Flank/axilla symptom/complaint

2.6

10.0

299

79199

ICD-8 Finland

Headache

5.8

10.0

R03AK08

ATC

formoterol and beclometasone; inhalant

3.3

9.9

153

UJH02

NOMESCO Finland

Anoscopy

2.8

9.9

226

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

9.9

299

2045

G47.9

ICD-10 Finland

Sleep disorder, unspecified

5.5

9.8

M77.1

ICD-10 Finland

Lateral epicondylitis

2.1

9.8

110

546

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

2.0

9.8

128

673

U02

ICPC

Urinary frequency/urgency

1.9

9.7

136

734

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.7

9.7

237

G45.3

ICD-10 Finland

Amaurosis fugax

55.4

9.7

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.0

9.6

121

627

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

2.1

9.6

111

557

-1

NOMESCO Finland

1.5

9.6

432

3233

P74

ICPC

Anxiety disorder/anxiety state

2.8

9.6

219

R03AC12

ATC

salmeterol; inhalant

3.0

9.6

180

M22.4

ICD-10 Finland

Chondromalacia patellae

2.9

9.6

203

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.1

9.6

169

F01

ICPC

Eye pain

3.6

9.6

115

KH1AD

NOMESCO Finland

CT of urinary organs

3.3

9.5

147

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.3

9.5

398

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

4.8

9.5

R1250

NOMESCO Finland

Evaluation of functional capability

4.1

9.5

R60.0

ICD-10 Finland

Localized oedema

2.1

9.4

107

532

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

9.4

188

1146

F45.0

ICD-10 Finland

Somatization disorder

17.7

9.4

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.8

9.4

206

AAW01

NOMESCO Finland

Implantation of intracranial stimulation device

+∞

9.4

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

+∞

9.4

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

+∞

9.4

N30.9

ICD-10 Finland

Cystitis, unspecified

2.7

9.4

248

C10AA01

ATC

simvastatin; oral

1.5

9.4

356

2564

R12

ICD-10 Finland

Heartburn

2.2

9.3

429

W22

ICD-10 Finland

Striking against or struck by other object(s)

2.2

9.3

417

SPAT1260

SPAT

Consultation of another employee

1.7

9.3

201

1251

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

3.2

9.3

150

F90.0

ICD-10 Finland

Disturbance of activity and attention

3.5

9.3

123

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.1

9.3

106

529

K04.08

ICD-10 Finland

Other specified pulpit

2.2

9.2

447

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

3.0

9.2

184

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

9.2

200

1251

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.9

9.2

141

789

N07BA03

ATC

varenicline; oral

2.3

9.2

371

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.4

9.2

340

V49.9

ICD-10 Finland

Car occupant [any] injured in unspecified traffic accident

2.8

9.1

208

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.1

9.1

102

503

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.9

9.1

127

687

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.8

9.0

100

J01

ICD-10 Finland

Acute sinusitis

2.5

9.0

277

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

3.1

9.0

159

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

3.3

9.0

137

E0000UV

ATC

1.5

9.0

461

3529

E66.9

ICD-10 Finland

Obesity, unspecified

3.5

9.0

121

A07AA02

ATC

nystatin; oral

2.5

9.0

278

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

9.0

843

7228

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

4.6

9.0

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.0

9.0

120

635

R06.2

ICD-10 Finland

Wheezing

2.8

9.0

203

XKD00

NOMESCO Finland

Uroflowmetry

1.9

9.0

139

778

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.8

9.0

204

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

3.7

9.0

101

N03

ICPC

Pain face

7.5

8.9

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.1

8.9

155

N80.3

ICD-10 Finland

Endometriosis of pelvic peritoneum

3.0

8.9

176

J04.0

ICD-10 Finland

Acute laryngitis

3.1

8.9

150

R13

ICD-10 Finland

Dysphagia

2.5

8.9

263

N06BA04

ATC

methylphenidate; oral

4.0

8.9

R00.2

ICD-10 Finland

Palpitations

2.3

8.9

386

H02AB09

ATC

hydrocortisone; systemic

3.9

8.9

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.4

8.8

123

J31.0

ICD-10 Finland

Chronic rhinitis

2.1

8.8

100

495

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

8.8

140

794

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.9

8.8

130

715

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

3.7

8.8

103

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.9

8.7

139

786

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.5

8.7

278

L15

ICPC

Knee symptom/complaint

1.6

8.7

223

1459

F61.0

ICD-10 Finland

Mixed personality disorders

4.1

8.7

G40

ICD-10 Finland

Epilepsy

50.3

8.7

C01DA14

ATC

isosorbide mononitrate; oral

2.0

8.7

102

517

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

8.6

469

3628

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

5.5

8.6

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

8.6

241

1613

R63.4

ICD-10 Finland

Abnormal weight loss

3.3

8.6

126

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

8.6

920

8049

AA1BD

NOMESCO Finland

Extensive CT of head and brain

4.1

8.6

SPAT1153

SPAT

Removal of sutures

1.5

8.6

338

2447

R03AC13

ATC

formoterol; inhalant

2.7

8.6

223

R25.2

ICD-10 Finland

Cramp and spasm

3.8

8.6

M02AA10

ATC

ketoprofen; topical

1.7

8.6

170

1031

P20

ICPC

Memory disturbance

2.3

8.5

367

B01AA03

ATC

warfarin; systemic

1.8

8.5

150

879

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.6

8.5

230

1525

A03FA02

ATC

cisapride; oral, rectal

2.3

8.5

360

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

5.2

8.5

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

8.5

190

1194

D07AC13

ATC

mometasone; topical

1.5

8.4

339

2465

N06AX05

ATC

trazodone; oral

3.3

8.4

128

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.8

8.4

147

856

U01

ICPC

Dysuria/painful urination

2.2

8.4

409

XCK00

NOMESCO Finland

Perimetry

2.4

8.4

310

R83

ICPC

Respiratory infection other

1.5

8.4

336

2440

M01AX05

ATC

glucosamine; oral

1.7

8.4

167

1018

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.8

8.4

186

G01AF05

ATC

econazole; vaginal

2.0

8.3

105

543

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

+∞

8.3

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

+∞

8.3

G40.10

ICD-10 Finland

Simple partial seizures

+∞

8.3

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.5

8.3

108

S80.0

ICD-10 Finland

Contusion of knee

2.2

8.3

404

N06AX18

ATC

reboxetine; oral

5.9

8.3

N20.9

ICD-10 Finland

Urinary calculus, unspecified

3.6

8.3

103

C10AA07

ATC

rosuvastatin; oral

1.6

8.3

223

1476

XA402

NOMESCO Finland

ENMG

3.2

8.3

130

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.9

8.3

N80.0

ICD-10 Finland

Endometriosis of uterus

3.4

8.2

114

N95

ICPC

Tension headache

14.6

8.2

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.3

8.2

120

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

2.4

8.2

300

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

2.3

8.2

308

K04.00

ICD-10 Finland

Hyperemia of pulp

2.4

8.2

269

R75

ICPC

Sinusitis acute/chronic

2.5

8.2

243

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

5.2

8.2

LCA06

NOMESCO Finland

Biopsy of endometrium

1.8

8.2

143

834

R52.0

ICD-10 Finland

Acute pain

3.1

8.2

137

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

8.2

118

647

K04

ICPC

Palpitations/awareness of heart

2.5

8.1

244

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.2

8.1

355

J45.8

ICD-10 Finland

Mixed asthma

3.2

8.1

132

A02BA03

ATC

famotidine; systemic

2.9

8.1

165

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.0

8.1

149

N06AG02

ATC

moclobemide; oral

2.7

8.1

195

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.4

8.1

275

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

8.1

417

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.9

8.1

113

609

OAB72

NOMESCO Finland

Weight control and weight loss guidance

11.8

8.1

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.0

8.1

481

K29.7

ICD-10 Finland

Gastritis, unspecified

3.0

8.1

144

L16

ICPC

Ankle symptom/complaint

1.9

8.0

113

612

N02CA72

ATC

ergotamine, combinations with psycholeptics; oral

22.2

8.0

L29

ICPC

Musculoskeletal sympt/complt other

2.2

8.0

397

R06AE09

ATC

levocetirizine; oral

1.7

8.0

186

1184

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

3.5

8.0

101

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

8.0

318

N94.5

ICD-10 Finland

Secondary dysmenorrhoea

3.7

8.0

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.5

7.9

242

J01DC02

ATC

cefuroxime; systemic

2.2

7.9

380

B34.9

ICD-10 Finland

Viral infection, unspecified

2.8

7.9

169

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.1

7.9

455

R518

ICD-10 Finland

13.1

7.9

Z72.0

ICD-10 Finland

Tobacco use

3.3

7.9

113

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.6

7.9

SPAT1050

SPAT

Extensive neurological examination

3.7

7.9

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

3.8

7.9

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.9

7.9

121

677

K11.2

ICD-10 Finland

Sialoadenitis

3.0

7.9

141

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.7

7.9

186

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.3

7.8

294

A04AA01

ATC

ondansetron; systemic, rectal

2.2

7.8

369

R31

ICD-10 Finland

Unspecified haematuria

2.1

7.8

459

J35.0

ICD-10 Finland

Chronic tonsillitis

2.2

7.8

373

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.3

7.8

307

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.4

7.7

104

SPAT1216

SPAT

Assessment of functional ability

1.8

7.7

122

690

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.6

7.7

206

RK320

NOMESCO Finland

15.1

7.7

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

5.3

7.7

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

4.0

7.7

C08CA01

ATC

amlodipine; oral

1.5

7.7

308

2236

SPAT1283

SPAT

Restricted health certificate

1.5

7.7

256

1785

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

4.4

7.6

M01AG01

ATC

mefenamic acid; oral

3.1

7.6

127

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.8

7.6

123

702

K59.0

ICD-10 Finland

Constipation

2.5

7.6

227

A85

ICPC

Adverse effect medical agent

6.7

7.6

D09

ICPC

Nausea

2.5

7.6

246

H93.1

ICD-10 Finland

Tinnitus

2.2

7.6

339

SPAT1255

SPAT

Intravenous administration of medicine

2.2

7.6

361

SFA00

NOMESCO Finland

Small filling

1.7

7.6

153

934

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

3.1

7.6

128

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.0

7.6

492

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

8.9

7.5

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

7.5

153

938

J01FA15

ATC

telithromycin; oral

1.8

7.5

127

735

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

2.7

7.5

187

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

3.1

7.5

129

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.9

7.5

157

N02AC04

ATC

dextropropoxyphene; oral

3.0

7.5

135

P25

ICPC

Phase of life problem adult

2.5

7.4

232

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.2

7.4

349

119

Kela drug reimbursment

Trigeminal neuralgia or glossofaryngeusneuralgia

13.4

7.4

R04.2

ICD-10 Finland

Haemoptysis

3.2

7.4

114

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

4.4

7.3

G03DC03

ATC

lynestrenol; oral

3.1

7.3

120

J01MA06

ATC

norfloxacin; oral

1.7

7.3

144

872

J05AB01

ATC

aciclovir; systemic

1.5

7.3

234

1613

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

2.3

7.3

286

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

10.9

7.3

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

+∞

7.3

N02CX01

ATC

pizotifen; oral

+∞

7.3

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

+∞

7.3

PA2DG

NOMESCO Finland

Very extensive MRI examination of vessels in the head with high intensity magnet

+∞

7.3

D07AC01

ATC

betamethasone; topical

1.4

7.3

370

2808

D10

ICPC

Vomiting

2.1

7.3

393

WX702

NOMESCO Finland

Supraglottic ventilation device

2.2

7.3

311

XKD06

NOMESCO Finland

Physiologic investigation of micturition

3.4

7.2

M01AE52

ATC

naproxen and esomeprazole; oral

2.8

7.2

170

XJH00

NOMESCO Finland

Transanal ultrasonography

2.5

7.2

210

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.6

7.2

195

M18.0

ICD-10 Finland

Primary arthrosis of first carpometacarpal joints, bilateral

5.5

7.2

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

4.3

7.2

Z01.7

ICD-10 Finland

Laboratory examination

1.8

7.2

123

713

GD1AA

SPAT

1.9

7.2

519

L50.9

ICD-10 Finland

Urticaria, unspecified

2.6

7.2

186

R03DA04

ATC

theophylline; systemic, rectal

2.6

7.2

197

K59.1

ICD-10 Finland

Functional diarrhoea

2.4

7.2

242

SPAT1094

SPAT

Continuous Positive Airway Pressure

30.2

7.2

R03BC03

ATC

nedocromil; inhalant

2.1

7.1

399

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

7.1

122

706

L50.0

ICD-10 Finland

Allergic urticaria

3.0

7.1

128

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.4

7.1

R35

ICD-10 Finland

Polyuria

2.3

7.1

275

C08DB01

ATC

diltiazem; oral

2.8

7.1

157

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.8

7.1

151

M76.0

ICD-10 Finland

Gluteal tendinitis

3.9

7.1

P29

ICPC

Psychological sympt/compl other

2.1

7.1

356

A01AB04

ATC

amphotericin B; local oral

2.7

7.1

175

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.8

7.0

111

629

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

4.7

7.0

N76.0

ICD-10 Finland

Acute vaginitis

2.1

7.0

381

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

3.5

7.0

N81.6

ICD-10 Finland

Rectocele

2.3

7.0

291

R29

ICPC

Respiratory symptom/complaint other

2.2

7.0

337

L04

ICPC

Chest symptom/complaint

2.2

7.0

304

SPAT1262

SPAT

Handing over of treatment supplies

1.6

7.0

174

1129

R2110

NOMESCO Finland

Giving the first information

2.0

7.0

468

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.1

6.9

352

L13

ICPC

Hip symptom/complaint

1.7

6.9

139

848

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

2.1

6.9

353

R5599

NOMESCO Finland

Other rehabilitation service

3.1

6.9

114

R03AK11

ATC

formoterol and fluticasone; inhalant

3.1

6.9

114

K07.58

ICD-10 Finland

Other abnormal function of teeth and jaws

7.6

6.9

E66

ICD-10 Finland

Obesity

2.6

6.9

190

WX725

NOMESCO Finland

Noninvasive ventilation

2.4

6.8

246

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.5

6.8

198

D07AD01

ATC

clobetasol; topical

1.6

6.8

165

1060

R20.0

ICD-10 Finland

Anaesthesia of skin

8.3

6.8

M01AX01

ATC

nabumetone; oral

2.6

6.8

191

H02.4

ICD-10 Finland

Ptosis of eyelid

3.1

6.8

110

EB1MA

NOMESCO Finland

Cephalometry with X-ray

4.0

6.8

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

4.0

6.8

DM1BD

NOMESCO Finland

Extensive CT of paranasal sinuses and face area

9.4

6.8

WX400

NOMESCO Finland

Inhalation anesthesy

2.3

6.8

269

SGB30

NOMESCO Finland

Other demanding filling of root channel of tooth

1.7

6.8

152

956

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.1

6.8

359

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

3.9

6.8

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

6.8

107

607

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

6.8

387

G24.9

ICD-10 Finland

Dystonia, unspecified

16.8

6.7

L29.9

ICD-10 Finland

Pruritus, unspecified

3.1

6.7

111

EMB10

NOMESCO Finland

Tonsillectomy

2.0

6.7

418

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

6.7

331

M01AE51

ATC

ibuprofen, combinations; systemic

3.8

6.7

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.7

6.7

152

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

22.6

6.7

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

4.9

6.7

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.9

6.6

526

A10BH01

ATC

sitagliptin; oral

2.0

6.6

410

R06AX26

ATC

fexofenadine; oral

2.0

6.6

425

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.6

6.6

171

N06AX17

ATC

milnacipran; oral

4.6

6.6

WX704

NOMESCO Finland

Intubation

2.0

6.6

427

G93.3

ICD-10 Finland

Postviral fatigue syndrome

12.3

6.6

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.8

6.6

C08CA05

ATC

nifedipine; systemic

2.2

6.6

301

SXA20

NOMESCO Finland

Local application of medicine to mouth

2.1

6.6

363

F43.00

ICD-10 Finland

Acute stress reaction mild

3.0

6.5

119

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.1

6.5

327

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.4

6.5

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

2.6

6.5

166

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.0

6.5

406

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

3.2

6.5

103

N29

ICPC

Neurological sympt/complt other

4.5

6.5

C08CA06

ATC

nimodipine; systemic

70.2

6.4

JEA00

NOMESCO Finland

Appendectomy

2.0

6.4

425

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

4.7

6.4

U07

ICPC

Urine symptom/complaint other

2.3

6.4

244

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

2.0

6.4

400

DHB50

NOMESCO Finland

Turbinoplasty

2.9

6.4

131

JN4BD

NOMESCO Finland

Extensive body CT

1.8

6.4

107

618

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

6.4

403

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

4.4

6.4

G04BD12

ATC

mirabegron; oral

2.0

6.4

432

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.5

6.3

188

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.8

6.3

115

680

UDC00

NOMESCO Finland

Ear microscopy

2.0

6.3

377

T90

ICPC

Diabetes non-insulin dependent

1.5

6.3

192

1305

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

6.3

280

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

11.1

6.3

S29

ICPC

Skin symptom/complaint other

1.6

6.3

167

1098

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.7

6.3

133

825

A06AC51

ATC

ispaghula, combinations; systemic

2.3

6.3

228

PA6CG

NOMESCO Finland

Extensive MRI examination of neck vasculature with high intensity magnet

18.1

6.3

GAE40

NOMESCO Finland

Operation on rib and soft tissues for thoracic outlet syndrome

18.1

6.3

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.8

6.3

547

SPAT1312

SPAT

General health counselling

1.4

6.3

367

2847

WZA00

NOMESCO Finland

Short statement of of health and health related matters

2.0

6.3

398

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

+∞

6.3

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.6

6.2

159

1034

M01AB08

ATC

etodolac; oral

1.9

6.2

456

F60.5

ICD-10 Finland

Anankastic personality disorder

4.3

6.2

XG410

NOMESCO Finland

Flow-volume spirometry

2.6

6.2

175

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.0

6.2

372

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.9

6.2

443

TAC99

NOMESCO Finland

Other blockade for chronic pain

7.1

6.2

C05AA08

ATC

fluocortolone; rectal, topical

1.6

6.2

154

996

N05AF01

ATC

flupentixol; systemic

3.9

6.2

M75.8

ICD-10 Finland

Other shoulder lesions

2.6

6.2

159

R07.1

ICD-10 Finland

Chest pain on breathing

3.8

6.2

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

4.5

6.2

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

3.0

6.2

113

R30.0

ICD-10 Finland

Dysuria

2.6

6.1

160

N06AB05

ATC

paroxetine; oral

2.0

6.1

380

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.6

6.1

152

985

N39.3

ICD-10 Finland

Stress incontinence

2.0

6.1

353

S00.0

ICD-10 Finland

Superficial injury of scalp

3.6

6.1

C10AX09

ATC

ezetimibe; oral

1.8

6.1

550

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

3.7

6.1

M01AB51

ATC

indometacin, combinations; oral, rectal

3.1

6.1

S01GX02

ATC

levocabastine; ophthalmic

1.9

6.1

426

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

6.1

552

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.9

6.1

124

G04BD04

ATC

oxybutynin; oral, transdermal

2.5

6.0

190

R06AX13

ATC

loratadine; oral

1.5

6.0

192

1320

J05AB11

ATC

valaciclovir; oral

1.6

6.0

151

980

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

6.0

100

574

F41.00

ICD-10 Finland

Moderate panic disorder

3.5

6.0

L99

ICPC

Musculoskeletal disease other

3.5

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

627

2777

3.09

98.04

2.5

2.0

129.79

228.74

u/l

1.99

594

2631

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

860

4986

2.60

74.46

6.6

6.3

1.21

mmol/l

0.07

749

4261

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

794

4455

2.58

73.29

6.2

5.8

1.21

mmol/l

0.17

745

4075

(3036481) Cortisol [Moles/volume] in Serum or Plasma

272

925

3.35

63.75

2.3

2.1

336.55

379.74

nmol/l

3.52

251

859

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

667

3678

2.41

60.87

4.1

2.8

21.93

54.41

ng/l

2.04

374

2172

(3013826) Glucose [Moles/volume] in Serum or Plasma

975

6364

2.40

60.09

5.9

4.3

6.35

6.56

mmol/l

3.22

935

5857

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

511

2534

2.51

58.51

1.9

1.7

0.91

1.07

mg/l

0.69

368

1888

(3018418) pH of Serum or Plasma

559

2902

2.44

57.76

3.6

3.9

7.39

7.40

0.38

520

(3024561) Albumin [Mass/volume] in Serum or Plasma

746

4405

2.32

57.16

4.5

4.8

36.44

36.31

g/l

0.27

702

4132

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1208

8853

2.58

54.91

8.1

7.1

75.58

75.94

u/l

0.11

1159

8347

(3013707) Erythrocyte sedimentation rate by Westergren method

1192

8738

2.51

53.16

4.8

3.6

9.56

10.51

mm/h

2.10

1129

8121

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

603

3352

2.30

52.14

3.2

2.4

52.78

56.81

u/l

2.81

568

3117

(3018677) aPTT in Platelet poor plasma by Coagulation assay

326

1380

2.72

50.90

2.3

2.2

29.47

29.81

0.26

316

1336

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

860

5674

2.14

46.84

6.6

6.2

9.82

11.17

umol/l

2.59

807

5404

(3013115) Eosinophils [#/volume] in Blood

910

6144

2.14

46.54

5.9

6.2

0.18

0.19

e9/l

0.81

823

5469

(3006315) Basophils [#/volume] in Blood

887

5940

2.13

46.23

5.8

5.9

0.04

e9/l

0.07

788

5201

(3001604) Monocytes [#/volume] in Blood

883

5922

2.12

45.60

5.7

5.8

0.57

0.56

e9/l

0.47

787

5191

(3031040) Bacteria [#/volume] in Urine by Automated count

1049

7541

2.18

44.80

5.5

3.6

128.55

1731.91

e6/l

1.21

(3037467) Urinalysis macro (dipstick) panel - Urine

1104

8109

2.22

44.46

5.1

3.7

—

(3019198) Lymphocytes [#/volume] in Blood

900

6123

2.10

44.20

5.7

5.9

2.00

1.94

e9/l

1.06

818

5468

(3032080) INR in Blood by Coagulation assay

643

3870

2.12

43.74

6.6

6.9

1.10

1.17

inr

2.01

200

1168

(3013650) Neutrophils [#/volume] in Blood by Automated count

971

6849

2.09

42.60

8.5

9.2

4.12

3.99

e9/l

1.03

875

6029

(3006504) Eosinophils/100 leukocytes in Blood

834

5572

2.06

42.35

5.8

6.0

2.63

2.83

2.34

795

5216

(3019069) Monocytes/100 leukocytes in Blood

837

5608

2.05

42.06

6.1

6.3

8.25

8.49

1.56

798

5286

(3002030) Lymphocytes/100 leukocytes in Blood

857

5806

2.05

41.60

5.9

6.0

29.32

28.89

0.59

810

5450

(3018010) Neutrophils/100 leukocytes in Blood

848

5733

2.04

41.29

5.7

5.8

56.36

56.59

0.23

807

5405

(3022096) Basophils/100 leukocytes in Blood

810

5387

2.04

41.28

5.8

6.1

0.68

0.03

768

5052

(3015377) Calcium [Moles/volume] in Serum or Plasma

579

3436

2.08

40.08

2.9

3.4

2.34

2.35

mmol/l

1.13

524

3093

(3044889) 12 lead EKG panel

1092

8150

2.11

39.83

4.1

3.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1216

9476

2.25

39.44

4.8

3.7

14.49

14.58

pmol/l

0.58

1146

8757

(42870588) Differential panel, method unspecified - Blood

617

3772

2.05

39.18

5.5

6.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

404

2102

2.24

39.07

1.4

1.2

23.07

32.13

iu/ml

0.78

127

652

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

645

4012

2.03

38.99

2.1

1.8

95.32

96.14

pmol/l

0.17

342

2137

(3033658) Prothrombin time (PT) actual/Normal

497

2817

2.12

38.61

4.8

3.8

94.64

93.80

0.32

479

2746

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

194

4.80

38.41

1.3

1.2

4.97

14.71

e6/l

1.13

148

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

194

4.80

38.41

1.4

1.3

179.60

1583.69

e6/l

0.86

152

(3018095) Leukocytes [#/volume] in Urine

624

3853

2.03

38.34

4.3

3.3

56.32

78.00

e6/l

0.65

448

2632

(3002582) Erythrocytes [#/volume] in Urine

543

3200

2.06

37.86

3.7

2.9

30.44

86.54

e6/l

1.26

423

2428

(3037522) Nuclear Ab [Titer] in Serum

333

1617

2.34

37.81

1.4

1.3

531.54

495.43

titre

0.11

337

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

618

3830

2.01

37.35

3.8

2.9

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

201

4.58

35.86

1.3

1.1

3.65

3.73

mmol/l

0.27

188

(36304419) Bacteria [Presence] in Urine

496

2879

2.06

35.64

3.5

2.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

321

1575

2.30

35.36

3.2

3.5

0.83

0.82

mmol/l

0.82

306

1499

(3044290) Cell count panel - Cerebral spinal fluid

192

4.62

35.12

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

355

1842

2.20

34.01

4.4

3.1

209.49

542.73

ng/l

1.15

215

1303

(3030467) Casts [#/volume] in Urine by Automated count

494

2912

2.02

33.67

3.6

2.8

0.39

0.44

e6/l

0.19

371

2159

(3021960) Folate [Moles/volume] in Serum or Plasma

387

2098

2.12

33.03

1.6

1.5

19.18

20.77

nmol/l

1.51

344

1833

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

697

4656

1.89

32.50

2.6

2.1

76.55

75.33

nmol/l

0.48

651

4283

(3023368) Bacteria identified in Blood by Culture

452

2614

2.02

32.28

4.9

4.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

230

1011

2.49

32.23

2.0

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1356

11374

2.40

31.97

5.9

4.3

1.71

2.10

mu/l

1.45

1295

10579

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

228

1003

2.49

31.88

2.0

1.7

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

298

1479

2.25

31.64

2.1

1.7

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

618

3998

1.90

31.58

3.5

3.2

27.94

36.47

u/l

1.41

598

3800

(3019550) Sodium [Moles/volume] in Serum or Plasma

1456

12650

3.06

31.56

19.5

11.7

139.64

139.66

mmol/l

0.09

1435

12297

(3009466) Valproate [Moles/volume] in Serum or Plasma

128

5.25

31.53

2.8

6.6

313.90

375.59

umol/l

2.18

110

(3023103) Potassium [Moles/volume] in Serum or Plasma

1459

12704

3.08

31.22

19.5

11.8

3.94

3.95

mmol/l

0.94

1437

12326

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1456

12674

3.03

30.97

18.6

10.9

18.74

22.43

mg/l

5.02

1227

9587

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

194

803

2.62

30.76

2.4

31.30

19.38

au/ml

—

(3035350) Ketones [Presence] in Urine by Test strip

811

5754

1.85

30.64

3.9

3.0

0.00

estimate

0.00

140

1033

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

367

2002

2.09

30.53

1.4

1.2

8.32

14.33

u/ml

1.18

143

815

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

470

2817

1.95

29.92

1.4

1.2

1.01

1.74

u/ml

1.41

126

786

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

440

2587

1.97

29.57

2.7

2.0

2.70

2.85

mg/l

0.81

385

2205

(3009261) Glucose [Presence] in Urine by Test strip

816

5842

1.83

29.53

3.9

3.1

0.00

estimate

0.50

141

1026

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

181

741

2.63

29.30

1.3

36.52

44.39

au/ml

—

(3021601) Nitrite [Presence] in Urine by Test strip

808

5780

1.82

29.20

5.3

4.2

0.00

estimate

0.50

145

1052

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

402

2317

1.99

28.46

2.7

2.8

820.95

1129.70

ng/l

0.76

320

1951

(3000570) Elastase.pancreatic [Mass/mass] in Stool

282

3.60

28.44

1.5

1.3

308.26

305.24

ug/g

0.04

153

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

330

1779

2.08

28.08

3.2

2.4

1.42

0.85

e6/l

0.90

190

996

(3026008) Bacteria identified in Urine by Culture

472

2885

1.91

28.02

3.1

2.5

—

(40768797) Stomach Pathology biopsy report

287

1472

2.16

27.80

1.4

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

124

428

3.06

27.58

3.5

3.7

5.09

5.08

kpa

0.04

113

402

(3019309) Folate [Moles/volume] in Red Blood Cells

298

1561

2.12

27.29

1.8

1.7

1164.78

1168.67

nmol/l

0.02

236

1230

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

229

1079

2.31

27.24

2.9

2.5

30.97

40.81

u/l

1.23

198

935

(3011397) Hemoglobin [Presence] in Urine by Test strip

431

2577

1.93

27.22

3.6

2.9

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

315

1689

2.08

27.11

3.3

2.6

4.98

2.63

e6/l

1.15

172

912

(3009343) pH of Capillary blood

121

420

3.04

26.64

3.6

3.8

7.44

7.42

1.03

(3048689) Calprotectin [Mass/mass] in Stool

291

1525

2.11

26.56

2.3

2.6

104.86

132.75

ug/g

0.63

237

1222

(3002032) Base excess in Venous blood by calculation

189

827

2.46

26.53

3.3

3.6

1.72

2.02

mmol/l

0.49

157

651

(3003396) Base excess in Arterial blood by calculation

217

1012

2.33

26.40

7.9

8.3

1.25

1.05

mmol/l

0.35

165

793

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

216

1015

2.31

25.79

7.9

8.3

5.00

5.10

kpa

0.93

211

974

(3027801) Oxygen [Partial pressure] in Arterial blood

215

1015

2.30

25.37

8.0

8.3

12.61

12.73

kpa

0.09

209

974

(3007164) IgA [Mass/volume] in Serum or Plasma

408

2451

1.90

25.11

1.6

1.4

2.20

2.35

g/l

0.83

236

1579

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

115

403

3.00

24.88

3.6

3.8

1.55

1.75

mmol/l

0.21

296

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

251

1276

2.15

24.66

2.5

2.8

6.96

7.82

umol/l

0.27

205

1120

(3023410) Appearance of Cerebral spinal fluid

5.47

24.57

1.3

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

751

5461

1.72

23.90

3.7

2.6

98.69

111.96

ug/l

1.12

716

5128

(3000850) Epithelial cells [#/volume] in Urine

364

2141

1.91

23.72

2.8

2.3

6.51

6.13

e6/l

0.17

322

1878

(3014576) Chloride [Moles/volume] in Serum or Plasma

238

1206

2.15

23.51

7.4

7.5

105.09

104.46

mmol/l

1.31

228

1182

(3019060) Gas panel - Arterial blood

136

540

2.66

23.28

5.2

4.3

—

(4010399)

164

716

2.44

23.04

1.4

—

(3016502) Oxygen saturation in Arterial blood

194

912

2.29

23.04

8.4

8.8

95.66

96.11

0.36

188

881

(3005322) IgE [Units/volume] in Serum or Plasma

174

784

2.37

22.78

1.4

1.3

136.39

228.79

u/ml

1.26

164

725

(3015171) Extractable nuclear Ab [Units/volume] in Serum

117

439

2.80

22.34

1.2

1.10

1.69

u/ml

0.22

(3026782) Osmolality of Urine

340

1997

1.90

22.08

2.9

2.6

536.62

560.46

mosm/kgh2o

1.09

293

1682

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

307

1751

1.94

21.76

2.7

3.0

2.42

2.44

mmol/l

1.82

275

1554

(40758558) Short blood count panel - Blood

459

2987

1.76

21.17

6.0

6.9

—

(3005719) IgG [Mass/volume] in Serum or Plasma

178

839

2.26

20.94

2.1

2.6

9.73

10.68

g/l

3.61

160

772

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

5.69

20.91

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

181

868

2.23

20.41

8.8

126.48

122.81

g/l

1.38

172

836

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

140

4.11

20.33

1.5

0.10

0.51

nmol/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

417

2679

1.76

19.93

1.7

1.5

—

(3019150) Specific gravity of Urine by Refractometry

390

2471

1.77

19.50

4.1

3.3

1.02

kg/l

0.10

339

(3007853) Bacteria identified in Skin by Aerobe culture

233

1255

2.01

19.33

1.9

1.6

—

(3021589) Normoblasts [#/volume] in Blood

718

5358

1.63

19.25

9.9

8.4

0.00

e9/l

0.43

594

4397

(3003458) Phosphate [Moles/volume] in Serum or Plasma

231

1246

2.00

19.07

4.3

6.0

1.01

1.03

mmol/l

0.37

214

1178

(3036489) Thrombin time

107

416

2.69

19.07

1.6

2.1

20.97

21.11

0.09

360

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

100

4.60

18.99

1.1

1.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

213

1120

2.04

18.87

17.7

19.0

1.06

1.23

inr

2.17

168

(1002224) Polysomnography panel

107

419

2.67

18.80

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

122

4.20

18.75

1.7

1.5

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

114

4.31

18.64

1.1

1.0

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

112

453

2.59

18.44

3.3

4.0

24.20

24.21

mmol/l

0.02

103

411

(3008152) Bicarbonate [Moles/volume] in Arterial blood

126

545

2.43

18.00

7.1

6.3

24.59

24.39

mmol/l

0.24

120

506

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1073

8913

1.64

17.95

3.9

2.8

47.64

44.26

u/l

0.63

1011

8447

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

325

2.84

17.87

1.8

1.6

0.23

0.24

g/l

0.72

307

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

156

748

2.21

17.53

2.4

3.3

4.43

4.59

pmol/l

1.43

138

672

(3004789) Transferrin [Mass/volume] in Serum or Plasma

249

1423

1.89

17.24

2.5

2.3

2.36

g/l

0.01

234

1318

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

146

686

2.24

17.23

1.9

1.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

338

2.76

17.15

1.8

1.6

1.22

1.16

g/l

0.89

319

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

139

644

2.27

16.97

2.2

2.6

92.85

163.93

ng/l

3.23

121

578

(3000991) Gas panel - Venous blood

160

788

2.15

16.80

8.4

9.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

733

5618

1.57

16.78

4.5

3.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

263

1547

1.84

16.59

2.5

2.3

13.61

14.01

umol/l

0.39

245

1426

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1273

11152

1.75

16.41

5.6

4.6

38.72

38.57

mmol/mol

0.23

1218

10482

(3022313) Gas panel - Capillary blood

285

2.87

16.23

3.9

4.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

185

3.33

16.10

2.8

2.9

25.29

25.08

mmol/l

0.13

164

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

128

3.84

15.99

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

112

485

2.41

15.95

1.6

2.0

37.35

40.02

u/l

0.81

102

443

(3024980) IgG subclass 4 [Mass/volume] in Serum

178

3.35

15.68

1.3

1.8

0.69

0.85

g/l

0.60

141

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1343

11997

1.82

15.56

4.6

3.7

5.80

5.79

mmol/l

0.14

1262

11142

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

126

3.81

15.54

1.4

1.5

—

nmol/l

—

(36660697) Celiac disease serology panel - Serum

181

964

1.99

15.36

1.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1476

13635

2.36

15.36

19.7

12.2

73.31

74.05

umol/l

0.52

1476

13628

(3013512) EKG study

419

2866

1.63

15.20

3.7

3.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

411

2.48

14.97

2.1

1.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

321

2063

1.70

14.77

1.8

1.6

77419769.21

23185560.55

pmol/l

0.61

279

1777

(3044640) Blood type and Crossmatch panel - Blood

510

3683

1.57

14.63

2.4

2.2

—

(3020630) Protein [Mass/volume] in Serum or Plasma

143

711

2.11

14.62

1.8

2.8

67.82

67.21

g/l

0.42

137

662

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1330

11903

1.77

14.57

15.1

10.0

89.03

87.30

ml/min/173m2

2.40

1141

9673

(3021387) Prolactin [Units/volume] in Serum or Plasma

121

564

2.24

14.54

2.3

1.6

298.31

309.21

mu/l

0.12

113

509

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

226

1319

1.83

14.51

2.6

2.4

22.60

24.06

0.85

192

1147

(3009508) Creatinine [Moles/volume] in Urine

453

3196

1.59

14.31

3.0

3.2

8.12

7.92

mmol/l

0.37

385

2746

(3009214) Lutropin [Units/volume] in Serum or Plasma

395

2.47

14.30

1.4

11.48

9.67

u/l

0.59

325

(3042936) Bacteria identified in Isolate by Culture

247

1487

1.78

14.30

2.2

2.0

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

4.12

14.04

1.3

2.93

3.16

g/l

0.34

(3024139) IgG subclass 3 [Mass/volume] in Serum

4.12

14.04

1.3

0.31

0.36

g/l

0.45

(3027135) IgG subclass 1 [Mass/volume] in Serum

4.12

14.04

1.3

6.39

6.51

g/l

0.11

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

5.48

14.03

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

292

2.68

13.89

2.0

3.2

—

(3022145) Colonoscopy Study observation

215

1253

1.83

13.84

1.3

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

4.43

13.83

1.2

1.1

252.90

259.32

mg/l

0.08

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

108

495

2.27

13.52

1.1

—

0.84

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

4.24

13.45

1.2

1.1

32.30

43.05

mg/l

1.03

(3028026) IgM [Mass/volume] in Serum or Plasma

135

678

2.08

13.44

1.6

1.8

1.10

1.42

g/l

1.67

122

627

(4062490)

4.05

13.39

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

596

4525

1.51

13.30

4.0

3.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

141

723

2.04

13.27

2.5

2.2

5.09

8.29

ug/l

1.05

119

654

(3016018) Differential panel - Cerebral spinal fluid

3.91

13.11

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

408

2865

1.57

12.95

2.3

5074.24

5167.96

umol/l

0.01

356

2552

(3013139) Helicobacter pylori Ag [Presence] in Stool

149

790

1.98

12.77

1.4

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

181

3.05

12.68

1.3

1.2

4.56

2.12

u/ml

0.66

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

187

3.01

12.60

1.5

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

187

3.01

12.60

1.5

1.2

—

(3011288) Drugs identified in Urine by Screen method

101

464

2.26

12.58

2.4

3.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

369

2.41

12.52

1.7

2.3

98.52

91.97

1.51

343

(3017446) Testosterone [Moles/volume] in Serum or Plasma

166

919

1.90

12.52

2.4

2.0

13.53

13.79

nmol/l

0.14

149

850

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

106

503

2.19

12.20

11.4

10.8

—

(40761511) CBC panel - Blood by Automated count

1459

13581

2.04

12.17

16.7

10.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

4.09

12.14

1.2

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

132

689

2.00

11.82

1.1

1.0

—

(3000494) Fungus identified in Specimen by Culture

217

1328

1.74

11.75

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

303

2024

1.62

11.75

2.0

2.1

—

(40768804) Tissue Pathology biopsy report

623

4871

1.46

11.57

2.1

2.0

—

(40760892) CBC W Ordered Manual Differential panel - Blood

397

2847

1.53

11.24

4.6

4.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

424

3085

1.51

11.20

1.7

1.6

1.51

1.36

mmol/l

1.84

363

2659

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

4.62

11.20

1.2

1.0

1.05

1.08

u/l

0.15

(3029937) Albumin [Presence] in Urine by Test strip

415

3010

1.51

11.12

4.5

3.3

0.02

0.01

estimate

0.32

145

1030

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

303

2.44

10.96

1.9

2.5

320.25

296.96

ug/l

0.05

285

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.95

10.75

1.1

1.0

—

(3024928) Oxygen saturation in Venous blood

199

2.77

10.74

2.9

2.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

389

2806

1.51

10.63

2.3

2.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

154

877

1.84

10.61

2.5

2.4

76.55

72.22

ml/min/173m2

0.63

301

(4027681)

4.28

10.57

1.3

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

5.82

10.54

1.1

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

373

2.26

10.48

1.3

1.1

—

(3020891) Body temperature

335

2.33

10.45

5.4

4.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

168

987

1.79

10.45

2.3

2.9

1.68

1.75

0.45

147

888

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1462

13716

1.95

10.42

12.3

8.8

27.73

26.97

u/l

0.73

1435

13283

(3014765) Yersinia sp identified in Stool by Organism specific culture

374

2.26

10.42

1.3

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

112

3.36

10.30

1.4

317.06

325.92

pmol/l

0.04

(3012516) Albumin [Mass/volume] in Urine

386

2799

1.50

10.24

3.1

3.2

1128.39

212.88

mg/l

1.59

238

1769

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

117

616

1.97

10.23

1.6

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

111

575

2.00

10.16

1.7

2.6

—

(3047181) Lactate [Moles/volume] in Blood

289

2.41

10.15

6.5

4.7

1.33

1.23

mmol/l

0.33

244

(42529406) Shigella sp [Presence] in Stool by Culture

379

2.23

10.10

1.3

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

265

1773

1.60

10.10

2.1

1.8

1.51

1.42

1.61

234

1604

(3048929) Epstein Barr virus Ab [Presence] in Serum

453

2.12

10.05

1.2

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

270

1817

1.59

10.03

1.9

2.0

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1074

9429

1.44

9.90

3.8

3.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

102

518

2.04

9.87

1.7

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

1215

10933

1.49

9.75

21.5

13.5

13.52

13.53

0.06

1198

10686

(3043409) Potassium [Moles/volume] in Arterial blood

270

2.43

9.72

4.5

4.1

3.89

3.84

mmol/l

0.40

252

(3011985) Renin [Units/volume] in Plasma

117

3.21

9.63

1.5

30.01

47.35

mu/l

0.79

100

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

185

2.70

9.34

1.3

1.2

2.75

2.80

u/ml

0.02

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.54

9.31

8.4

1.4

90.30

61.38

umol/l

0.67

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

174

2.75

9.30

1.7

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

136

778

1.82

9.24

1.6

1.3

27.21

28.36

iu/l

0.16

121

669

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

156

936

1.74

9.02

1.2

96.43

150.02

iu/ml

1.06

367

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

177

2.71

9.01

1.1

139.28

115.80

3.80

163

(3025941) Bacteria identified in Stool by Culture

124

696

1.85

8.96

1.4

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

101

530

1.97

8.94

2.0

2.2

—

(3021901) Oxygen saturation in Capillary blood

139

2.93

8.89

3.2

2.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

263

2.37

8.86

2.7

3.4

0.37

0.34

u/ml

0.28

141

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

192

1225

1.65

8.83

7.8

5.5

—

(1616796) Gas panel - Central venous blood

168

2.73

8.78

4.8

3.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

3.38

8.23

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

3.38

8.23

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

3.38

8.23

1.2

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

482

1.97

8.19

2.4

2.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

225

2.40

7.99

1.8

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

3.30

7.95

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

3.30

7.95

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

3.30

7.95

1.2

1.1

—

(3049717) Cytology report of Urine Cyto stain

350

2.11

7.87

2.2

2.5

—

(3012501) Base excess in Blood by calculation

178

2.57

7.87

4.6

3.4

2.28

2.50

mmol/l

0.21

111

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

221

2.40

7.83

1.8

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

464

1.95

7.71

1.7

—

(4198724)

3.56

7.71

1.9

2.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

3.46

7.68

1.2

1.06

1.03

ratio

0.55

(3020682) Albumin/Creatinine [Ratio] in Urine

387

2950

1.41

7.60

3.8

3.9

9.75

8.13

mg/mmol

0.23

233

1901

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

308

2.16

7.59

1.8

2.7

9.29

10.36

g/l

1.87

267

(3003181) Sodium [Moles/volume] in Urine

135

2.78

7.57

1.4

1.3

66.41

67.98

mmol/l

0.07

115

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

325

2.11

7.38

1.8

2.7

3.66

3.84

g/l

0.54

247

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

325

2.11

7.38

1.8

2.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

325

2.11

7.38

1.8

2.7

7.29

7.34

g/l

0.09

261

(3023520) Reticulocytes [#/volume] in Blood

119

702

1.75

7.31

2.3

3.0

67.67

71.25

e9/l

0.56

532

(4306422)

180

2.49

7.21

1.2

—

(40767503) Oxygen content in Capillary blood by calculation

168

2.54

7.21

4.2

2.3

16.81

16.56

0.13

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1375

12894

1.53

7.16

4.8

4.1

2.88

mmol/l

0.05

1295

12091

(46235355) HIV 1 and 2 tests - Meaningful Use set

387

2977

1.40

7.16

2.0

1.9

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

199

2.40

7.16

2.8

2.3

134.92

130.61

g/l

0.57

144

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

151

2.62

7.14

1.7

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

310

2.11

7.09

1.8

2.7

2.76

3.12

g/l

3.21

253

(3000060) B lymphocytes [#/volume] in Blood

5.69

7.07

1.5

1.7

263.33

261.82

e6/l

—

(3010421) pH of Blood

219

2.33

7.06

4.4

3.3

7.42

0.04

177

(3016879) Cocaine [Presence] in Urine

109

635

1.77

7.00

2.0

2.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

423

3313

1.38

7.00

3.6

2.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

191

2.40

6.83

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

121

2.76

6.72

1.1

1.2

—

(3022806) Fractional oxyhemoglobin in Capillary blood

100

2.94

6.60

2.7

1.8

92.11

89.79

2.36

100

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

319

2.05

6.60

1.3

1.2

—

8.48

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.98

6.55

1.4

2.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

123

758

1.68

6.47

3.0

3.4

1.22

1.23

mmol/l

0.28

111

655

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

254

2.17

6.47

1.4

0.24

0.37

nmol/l

1.99

207

(44816559) Phosphatidylethanol [Mass/volume] in Blood

268

2.13

6.43

1.3

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

350

1.99

6.43

1.5

1.2

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

3.32

6.42

1.2

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1355

12727

1.47

6.39

4.4

3.8

4.75

4.79

mmol/l

0.58

1285

12005

(3000764) Benzodiazepines [Presence] in Urine

114

696

1.69

6.22

2.0

2.2

—

(3052851) Hemolysis interference index of Serum or Plasma

293

2.05

6.16

2.6

3.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

247

2.14

6.10

1.3

1.2

39.33

32.38

u/ml

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

163

1093

1.55

6.07

3.4

4.6

215.17

251.35

u/l

2.62

156

1047

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

128

2.61

6.06

1.7

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

351

1.95

6.04

1.8

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

460

1.83

6.00

2.7

1.7

—

(3027008) Opiates [Presence] in Urine

114

703

1.67

6.00

2.0

2.2

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

3.89

5.99

1.5

1.1

—

71.00

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1347

12670

1.44

5.98

4.4

3.7

1.42

1.48

mmol/l

5.78

1278

11913

(3023420) DNA double strand Ab [Units/volume] in Serum

129

2.59

5.97

1.4

1.5

—

31.17

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

171

1164

1.53

5.95

2.3

1.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

3.70

5.93

1.2

—

(3028300) Cannabinoids [Presence] in Urine

114

706

1.66

5.91

2.0

2.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

149

986

1.56

5.89

2.1

2.4

0.23

0.22

g/l

0.25

139

926

(44790049)

114

2.66

5.75

1.4

1.5

—

(44790048)

114

2.66

5.75

1.4

1.5

—

(44790047)

114

2.66

5.75

1.4

1.5

—

(44806118)

114

2.66

5.75

1.4

1.5

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

3.93

5.72

1.1

0.29

g/l

0.01

(40761535) Cells panel - Urine sediment

129

834

1.60

5.64

3.5

2.9

—

(3023183) Ammonium ion [Moles/volume] in Plasma

209

2.19

5.60

4.3

3.1

32.90

36.53

umol/l

0.31

183

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.31

5.59

1.5

2.0

—

(3007461) Platelets [#/volume] in Blood

1513

14651

1.89

5.44

26.3

16.0

261.14

254.64

e9/l

3.86

1498

14284

(3011412) CD3 cells [#/volume] in Blood

2.84

5.42

1.4

2.7

1.53

1.11

e9/l

1.06

(3023419) Bacteria identified in Sputum by Culture

112

2.62

5.40

2.0

2.2

—

(3024731) MCV [Entitic volume]

1514

14667

1.89

5.39

26.2

15.9

90.93

90.55

2.69

1505

14481

(3027944) Amphetamines [Presence] in Urine

110

692

1.63

5.38

2.0

2.2

—

(3035941) MCH [Entitic mass]

1514

14668

1.89

5.37

26.1

15.9

30.36

30.25

1.75

1505

14480

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1296

12161

1.38

5.37

3.9

3.4

1.39

1.27

mmol/l

6.37

1224

11403

(3006653) Thiamine [Moles/volume] in Blood

3.75

5.37

1.3

126.81

143.80

nmol/l

0.79

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

359

1.88

5.35

1.0

1.1

2.14

4.05

u/ml

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

345

1.89

5.34

2.2

1.9

2.93

1.64

ug/l

0.45

309

(3026361) Erythrocytes [#/volume] in Blood

1514

14671

1.88

5.32

26.3

16.0

4.55

e12/l

0.31

1495

14286

(3011648) Oxygen content in Venous blood

2.94

5.31

2.6

2.3

10.17

11.09

0.41

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

4.64

5.26

1.1

—

(3010813) Leukocytes [#/volume] in Blood

1514

14676

1.87

5.24

26.3

16.0

6.87

6.63

e9/l

3.36

1495

14281

(3000963) Hemoglobin [Mass/volume] in Blood

1514

14679

1.87

5.19

26.5

16.1

137.17

137.09

g/l

0.09

1504

14493

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

264

2.00

5.16

2.8

2.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

100

622

1.65

5.12

1.0

1.1

—

169.31

—

(3019225) pH of Specimen

143

969

1.52

5.10

4.2

4.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

128

2.45

5.06

1.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

185

2.19

5.06

1.1

1.2

—

480.00

—

(3045414) Leukocytes [Presence] in Urine

493

1.72

5.05

2.1

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.58

5.05

1.0

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

5.29

5.04

1.3

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

5.29

5.04

1.3

1.1

84.80

92.21

—

(3008898) HLA-B27 [Presence]

510

1.70

4.99

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.91

4.99

1.1

—

(4268621)

129

2.43

4.98

2.6

2.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

346

1.86

4.98

1.2

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

2.69

4.92

2.6

6.3

11.42

7.20

mmol/l

0.44

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

137

2.36

4.84

1.9

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

11.48

4.78

1.0

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

265

1.96

4.77

1.9

2.8

41.50

38.16

g/l

3.61

236

(3017732) Neutrophils [#/volume] in Blood

123

819

1.54

4.76

2.0

2.8

3.91

4.05

e9/l

0.31

678

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

106

682

1.59

4.76

3.4

3.9

71.50

81.63

ng/l

0.85

617

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

2.69

4.76

1.1

1.2

0.13

0.64

u/ml

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

288

1.91

4.68

1.9

3.0

0.46

0.63

g/l

0.23

257

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

269

1.93

4.58

1.4

1.5

—

(3017181) Myelocytes/100 leukocytes in Blood

132

901

1.51

4.57

3.6

4.3

0.50

0.96

2.12

244

(3022621) pH of Urine by Test strip

110

722

1.56

4.55

2.4

2.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

174

2.15

4.52

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

122

821

1.53

4.51

3.2

4.2

0.52

0.67

0.20

182

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

2.88

4.50

1.5

1.9

7.33

14.65

3.08

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

3.61

4.49

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

264

1.92

4.48

1.2

234.03

247.77

u/ml

0.19

169

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

134

925

1.49

4.40

2.1

1.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

1308

12385

1.34

4.36

19.6

11.7

40.42

40.43

0.02

1028

9841

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

151

1077

1.44

4.20

3.2

2.7

—

(3034770) Mitochondria Ab [Titer] in Serum

336

1.79

4.20

1.1

1.3

—

1505.00

—

(3000492) Spirometry study

176

1293

1.41

4.16

1.5

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

189

1407

1.39

4.14

1.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

2.82

4.12

1.3

2.8

504.38

519.65

e6/l

0.04

(3017143) Hepatitis C virus Ab [Presence] in Serum

220

1682

1.36

4.09

1.8

1.6

—

(3030313) Adrenal Ab [Titer] in Serum

8.03

4.06

1.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.53

4.05

1.3

1.6

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

211

1.97

3.99

1.8

1.5

—

(3042631) Mycobacterium sp identified in Specimen

100

2.42

3.90

3.4

3.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

2.79

3.86

1.3

2.9

0.16

0.20

e9/l

0.70

(3003338) MCHC [Mass/volume]

1232

11630

1.27

3.79

23.2

13.6

333.16

333.17

g/l

0.01

1227

11541

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

347

1.73

3.79

1.7

1.3

—

(3017704) Immunofixation for Urine

3.20

3.78

1.1

1.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

281

1.80

3.75

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

112

773

1.48

3.71

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

128

2.21

3.71

1.9

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

401

3370

1.26

3.66

4.1

1.64

2.29

ug/l

3.33

356

3081

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

5.65

3.66

1.1

1.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

323

1.73

3.57

1.4

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

164

2.03

3.56

1.3

1.2

—

(3025159) Blasts/100 leukocytes in Blood

117

822

1.46

3.56

3.7

4.5

0.00

1.02

0.99

190

(3021440) Promyelocytes/100 leukocytes in Blood

121

859

1.44

3.49

3.6

4.4

0.00

0.14

5.22

221

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

173

1.99

3.45

1.4

2.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

173

1.99

3.45

1.9

1.5

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

2.78

3.42

1.0

1.1

106.18

91.55

0.80

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

306

1.72

3.37

2.0

1.6

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

248

1.80

3.30

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

651

1.49

3.29

2.3

2.2

6112.62

4193.79

u/l

0.24

258

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

2.52

3.21

1.5

1.8

0.75

2.50

u/field

1.22

(21494755) Public health laboratory ask at order entry panel

138

1837

0.73

3.19

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.35

3.19

1.0

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

104

2.23

3.16

1.3

1.1

—

(3008295) Osmolality of Serum or Plasma

104

2.23

3.16

1.5

1.4

283.44

281.26

mosm/kgh2o

0.15

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

186

1.90

3.16

1.6

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.74

3.16

1.5

—

(44813793)

2.37

3.15

1.1

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

201

1.86

3.13

1.0

1.1

3.24

2.21

u/ml

0.33

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

321

1.67

3.11

1.7

2.1

3.79

5.54

iu/l

0.88

121

(3013247) Albumin in CSF/Albumin in Serum or Plasma

4.52

3.11

1.0

7.59

8.67

mg/g

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

159

1.97

3.10

2.1

1.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

146

2.00

3.06

1.2

1.3

—

19.04

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

2.45

3.05

1.3

1.1

—

(40761536) Microorganisms panel - Urine sediment

132

978

1.38

3.02

4.4

3.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.30

2.99

1.4

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

4.30

2.99

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

10.03

2.98

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

3.02

2.97

1.2

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

257

1.73

2.96

1.6

1.5

110.29

108.12

u/ml

0.07

(3028679) Herpes simplex virus Ab [Presence] in Serum

2.56

2.96

1.3

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

250

1.74

2.94

1.6

4.5

26.50

32.43

mg/l

0.57

205

(3034860) Kappa light chains.free [Mass/volume] in Serum

250

1.74

2.94

1.6

4.5

39.81

95.92

mg/l

1.13

202

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

184

1.87

2.93

1.2

1.1

—

(3034426) Prothrombin time (PT)

2.94

2.86

1.5

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

276

1.69

2.82

1.4

1.5

—

9.33

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

4.46

2.79

2.8

3.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

2.56

2.79

1.1

1.5

4.66

9.09

u/l

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

2.18

2.77

1.2

1.6

51.36

59.85

0.33

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.02

2.73

1.1

1.3

—

(3051651) Icteric interference index of Serum or Plasma

2.44

2.71

2.3

4.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

204

1.78

2.70

1.2

1.1

4580.43

2545.48

iu/ml

—

(3032773) Endomysium IgG Ab [Titer] in Serum

127

1.98

2.61

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.68

2.60

4.4

1.4

9.67

14.56

umol/l

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.20

2.57

3.3

4.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.61

2.57

4.4

6.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

101

2.09

2.53

2.2

1.8

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

319

2716

1.22

2.51

4.0

3.5

21.87

21.42

0.18

122

1185

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

3.48

2.48

1.1

1.2

—

(44806071)

4.39

2.47

1.0

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

241

1.68

2.46

1.2

1.4

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.47

2.45

2.1

2.7

18.39

20.38

ug/l

0.26

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

360

1.55

2.43

2.1

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.95

2.41

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

5.01

2.40

1.0

—

(40760888) Immunoglobulin light chains.free panel - Serum

190

1.75

2.38

1.3

4.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.65

2.36

1.3

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.65

2.36

1.3

1.0

—

(4146454)

2.16

2.35

2.2

2.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

396

1.51

2.33

1.3

2.0

1.37

1.50

g/l

0.66

340

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

131

1013

1.32

2.32

3.1

4.4

73.36

30.39

ug/l

0.29

105

818

(3035320) C reactive protein [Mass/volume] in Body fluid

2.32

2.31

2.2

2.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.87

2.30

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

171

1.77

2.25

1.2

1.3

—

(3002619) Bacteria identified in Specimen by Culture

3.90

2.25

1.1

—

(3037756) Immunofixation for Serum or Plasma

164

1.78

2.24

1.4

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

248

1.63

2.23

2.0

1.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.12

2.22

1.7

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

225

1.66

2.22

1.4

1.5

—

(3051611) Lipemic interference index of Serum or Plasma

2.06

2.22

2.7

3.8

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

5.57

2.21

1.4

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.63

2.18

1.0

1.3

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

4.30

2.15

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

198

1.68

2.09

1.5

1.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

398

1.47

2.09

2.3

1.8

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

5.01

2.07

1.4

3.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

126

1592

0.77

2.06

1.8

1.7

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

4.01

2.04

1.8

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

4.01

2.04

1.8

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

4.01

2.04

1.8

1.0

—

(3042517) Benzodiazepines panel - Urine

4.01

2.04

1.3

3.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.41

2.02

1.0

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

118

1.88

2.02

1.3

1.1

52.94

56.94

u/l

0.34

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.09

2.01

1.8

2.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.09

2.01

1.8

2.0

—

(3029075) Extractable nuclear Ab panel - Serum

2.82

2.00

1.0

—

(3044927) Protein electrophoresis panel - Urine

2.04

1.96

1.2

1.1

—

(3025130) Human papilloma virus identified in Specimen

210

1.63

1.95

1.8

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.20

1.94

3.0

412.29

1028.88

u/ml

0.96

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.76

1.93

1.0

1.6

—

(40768443) Skin Pathology biopsy report

414

1.44

1.92

1.2

—

(4034850)

389

1.46

1.92

15.0

7.2

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

1.97

1.90

1.2

2.6

1081.40

745.20

e6/l

—

(3037121) Protein [Mass/volume] in Urine

357

1.47

1.90

2.8

3.5

0.30

0.24

g/l

0.21

160

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.40

1.85

1.1

1.2

138.82

110.59

1.04

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.54

1.84

1.7

1.1

—

(4094501)

294

1.51

1.83

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.18

1.82

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.58

1.80

1.7

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.10

1.76

2.4

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

139

1.74

1.76

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.99

1.75

1.4

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

2.51

1.74

1.0

—

196.25

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

125

1.77

1.72

3.3

3.2

0.85

0.83

nmol/l

0.06

100

(3000330) Specific gravity of Urine by Test strip

501

1.37

1.71

3.5

3.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.96

1.69

1.4

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

104

1.84

1.67

1.8

1.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.81

1.65

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

1.94

1.64

1.8

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

1.94

1.64

1.8

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

1.94

1.64

1.8

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

2.25

1.63

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.85

1.62

1.9

1.7

—

(4015189)

3.58

1.61

1.0

4.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

138

1133

1.24

1.58

1.6

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.01

1.58

1.0

1.4

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.70

1.58

1.1

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.70

1.58

1.1

1.2

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.70

1.58

1.1

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

2.70

1.58

1.1

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

274

1.47

1.52

1.2

1.1

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

3.34

1.52

5.6

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

250

1.49

1.51

2.7

2.5

1.11

0.81

nmol/l

0.96

216

(40768806) Pleura Pathology biopsy report

1.95

1.49

1.6

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

301

1.44

1.48

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

195

1.55

1.46

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

2.38

1.45

1.1

—

51.43

—

(3028433) Virus identified in Specimen by Culture

2.51

1.45

1.3

1.5

—

(3044941) Cell count panel - Synovial fluid

148

1.63

1.44

1.3

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.13

1.44

1.0

1.8

—

(3051593) INR in Capillary blood by Coagulation assay

3.13

1.44

5.6

15.3

—

(3052592) Norovirus Ag [Presence] in Stool

3.13

1.44

1.4

1.3

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.73

1.43

1.0

1.1

0.00

4.13

u/ml

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

196

1.54

1.43

2.8

3.8

4.44

3.81

e9/l

1.01

196

(3002256) Pathology report gross observation

176

1499

1.20

1.42

1.2

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

272

1.44

1.38

1.2

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

121

0.41

1.37

1.0

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.61

1.37

1.2

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.61

1.37

1.5

2.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.95

1.36

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.51

1.30

1.0

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.77

1.29

1.3

1.1

—

(3003694) ABO and Rh group [Type] in Blood

419

3836

1.13

1.29

1.5

—

(3001556) Androgen free Index in Serum or Plasma

2.78

1.28

1.0

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.09

1.27

1.5

3.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1086

0.80

1.26

1.6

1.4

—

(4024509)

1.83

1.25

1.7

1.4

—

(3020491) Glucose [Moles/volume] in Blood

1.83

1.25

1.6

1.8

7.56

6.33

mmol/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

115

1.66

1.25

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.41

1.24

1.2

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.86

1.24

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

150

1278

1.19

1.23

4.6

3.6

31.60

31.98

0.16

114

883

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.64

1.21

1.0

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.64

1.21

1.4

1.9

6.92

7.28

mmol/l

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

197

1.48

1.19

2.7

2.2

6.77

5.51

umol/l

0.19

146

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

206

1.47

1.18

2.9

4.0

58.80

56.27

0.77

206

(3043410) Blood group antigens tested for on Red Blood Cells

2.06

1.15

1.4

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.34

1.12

2.0

1.3

—

(3010503) CD19 cells [#/volume] in Blood

1.90

1.12

1.3

3.0

0.23

0.17

e9/l

0.42

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.97

1.11

2.7

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.97

1.11

2.7

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

193

1.46

1.09

1.1

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

235

1.41

1.09

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

112

1.61

1.09

1.0

1.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

330

1.34

1.08

2.5

3.2

1.27

1.39

mg/l

0.42

306

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

1.87

1.07

2.6

2.4

202.91

192.41

u/l

0.13

(3014271) Vancomycin [Susceptibility]

2.13

1.05

4.0

2.5

—

(3004451) EKG impression Narrative

2.13

1.05

1.6

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.67

1.04

3.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.84

1.03

2.5

1.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.92

1.02

2.2

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.92

1.02

2.2

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.92

1.02

2.2

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.92

1.02

2.2

1.8

—

(3021788) Differential panel - Synovial fluid

163

1.48

1.02

1.3

1.6

—

(4211845)

1.88

1.00

2.0

2.6

—

(1761868) Lipid panel - Serum or Plasma

488

5204

0.91

0.99

2.6

2.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

1.72

0.99

1.5

1.6

25.29

28.37

—

(3000012) Reticulocyte production index

1.84

0.98

1.2

2.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.18

0.98

5.4

5.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.95

0.97

1.7

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

100

1.61

0.97

2.4

2.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

101

1.59

0.93

1.1

1.0

0.26

2.29

u/ml

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

375

1.29

0.92

2.7

3.9

126.64

3496.85

u/ml

0.69

321

(3005570) Glucose [Moles/volume] in Urine

102

1.57

0.90

2.0

1.7

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

143

1.47

0.90

1.6

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

382

0.73

0.90

1.6

1.7

—

(3045424) Erythrocytes [Presence] in Urine

185

1.41

0.89

1.8

1.4

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

261

2379

1.12

0.88

1.5

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

522

1.24

0.87

1.3

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

266

2432

1.11

0.85

1.7

—

(3000475) Leukocytes [#/volume] in Synovial fluid

230

1.35

0.85

1.4

1.7

5124.67

10309.46

e6/l

0.86

166

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.63

0.84

1.1

1.2

—

(3041354) Potassium [Moles/volume] in Venous blood

104

1.54

0.84

2.4

2.3

4.06

3.98

mmol/l

0.43

104

(3035285) Chloride [Moles/volume] in Venous blood

104

1.54

0.84

2.4

2.3

106.00

105.61

mmol/l

0.18

104

(3006462) Nitrate [Presence] in Urine

1.78

0.84

2.1

2.6

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.74

0.82

1.0

1.1

—

14.66

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

232

1.34

0.81

1.2

1.1

—

(44806420)

0.00

0.79

0.0

2.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

316

0.72

0.79

1.5

1.6

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

593

1.21

0.79

1.8

2.18

3.84

mg/l

1.85

391

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.63

0.78

1.9

2.0

—

(3012441) Differential panel - Pleural fluid

1.63

0.78

1.8

1.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.77

0.76

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.70

0.75

1.0

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.85

0.73

2.6

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.85

0.73

2.6

2.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.85

0.73

3.3

2.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

2.00

0.72

1.2

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.80

0.72

2.6

2.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.61

0.72

1.0

1.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.67

0.68

2.9

3.2

—

(3045788) Cell count panel - Pleural fluid

1.53

0.68

1.7

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

180

1636

1.11

0.67

1.5

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

268

1.27

0.65

1.1

5.65

7.62

u/ml

0.28

131

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.62

0.65

1.1

1.6

—

1494071.43

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

1.62

0.65

1.5

1.1

71.20

82.89

u/l

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.73

0.64

1.6

1.2

—

(3004809) Band form neutrophils/100 leukocytes in Blood

146

1.37

0.64

2.0

3.9

0.75

1.54

0.89

121

(4035726)

1005

0.87

0.62

1.2

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

104

1.45

0.62

1.7

2.1

18.00

20.11

mg/l

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

1.59

0.61

1.5

1.1

6.30

14.72

u/l

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.59

0.61

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

536

1.18

0.61

1.5

1.3

276.10

219.26

miu/ml

0.54

275

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

209

1.30

0.60

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.60

0.0

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

210

1.29

0.59

1.2

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

282

1.25

0.58

1.1

2.11

1.52

u/ml

0.12

110

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

484

1.18

0.57

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

238

1.27

0.57

4.6

4.3

—

(3035880) pH of Pleural fluid

1.67

0.56

1.2

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

133

1.36

0.55

1.1

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.58

0.54

1.7

2.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.54

0.53

1.5

1.9

—

(3016228) CD19 cells/100 cells in Blood

1.54

0.53

1.5

2.0

9.50

8.41

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

127

1.34

0.49

1.5

1.6

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

254

1.22

0.47

1.1

0.58

1.60

u/ml

0.82

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.39

0.46

1.5

1.6

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.61

0.45

1.4

1.2

—

(40768795) Lymph node Pathology biopsy report

120

0.66

0.45

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

1.40

0.45

1.4

1.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

534

0.86

0.44

1.6

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

130

1.31

0.44

1.5

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

130

1.31

0.44

1.5

1.6

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.38

0.41

1.5

1.1

—

(3019174) dRVVT (LA screen)

0.00

0.41

0.0

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

0.00

0.41

0.0

2.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.47

0.40

1.8

1.6

—

(3020650) Glucose [Presence] in Urine

1.47

0.40

1.8

1.2

—

(4133840)

1.43

0.39

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

251

1.20

0.39

1.1

0.67

3.02

u/ml

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

106

1.32

0.39

1.7

1.4

21.78

63.72

pmol/l

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

178

1.24

0.39

2.3

2.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.35

0.37

1.0

3.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

216

2044

1.07

0.37

2.5

2.6

0.67

0.72

ug/l

0.31

128

1232

(3003434) Protein [Mass/volume] in Pleural fluid

1.32

0.33

1.8

1.5

39.45

33.38

g/l

0.67

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.32

0.33

1.3

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

1.33

0.33

56.5

29.9

105.33

136.51

ug/l

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

127

1.26

0.33

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

127

1.26

0.33

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.28

0.32

2.0

1.5

10.15

8.17

ug/l

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.28

0.32

1.3

1.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

128

1.25

0.32

1.5

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.31

0.32

1.2

1.6

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.72

0.31

1.4

3.3

20.47

61.22

u/ml

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

901

0.92

0.30

1.4

1.5

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.27

0.30

1.0

1.1

82.23

242.49

iu/ml

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.25

0.29

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

167

1.20

0.28

1.1

1.3

—

(21494434) Karyotype in Bone marrow

1.28

0.26

1.2

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.70

0.26

1.2

—

(40768800) Prostate Pathology biopsy report

192

0.83

0.25

1.3

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.22

0.25

4.2

7.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

297

0.87

0.24

1.4

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

255

1.14

0.24

1.8

1.6

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

180

1.17

0.23

1.1

1.89

0.43

u/ml

—

(3035933) Granulocytes/100 leukocytes in Blood

1.28

0.23

1.4

2.1

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.21

0.0

5.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

1.23

0.21

2.6

4.9

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

126

1.19

0.21

1.1

2.3

33.73

32.50

0.96

126

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.20

0.0

1.1

—

(3024932) HLA-DR beta [Type]

1.25

0.20

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

403

1.09

0.20

1.5

1.4

—

(3024471) HLA-A [Type]

1.23

0.20

1.0

—

(3042733) HLA Ab [Presence] in Serum

1.20

0.19

6.3

5.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

250

1.12

0.19

4.2

3.1

19.13

25.35

mg/l

0.37

158

(40768446) Kidney Pathology biopsy report

1.18

0.19

1.5

1.6

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

331

0.90

0.18

1.3

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

525

0.93

0.16

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

923

0.95

0.15

1.8

1.7

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

119

0.84

0.15

1.1

1.6

0.91

0.97

g/l

—

119

(3015183) Erythrocyte sedimentation rate

1.10

0.15

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.81

0.14

1.0

1.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

1.19

0.14

1.1

1.4

163.40

88962.51

e6/l

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.81

0.13

1.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

412

1.07

0.13

1.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

199

1.11

0.13

1.1

3.46

3.58

u/ml

0.02

(3045142) Bone marrow Pathology biopsy report

106

0.85

0.13

1.3

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

413

1.07

0.13

1.6

412.50

0.30

iu/ml

—

(40768793) Breast Pathology biopsy report

303

0.92

0.12

1.1

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

405

1.06

0.11

1.5

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

191

1.10

0.11

1.2

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.09

0.09

1.2

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.09

0.09

1.2

1.9

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

483

0.95

0.09

1.5

1.4

—

(3024263) Appearance of Synovial fluid

1.06

0.09

1.4

2.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.13

0.09

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

431

0.95

0.09

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

175

1.09

0.08

1.5

3.1

6.26

28.65

u/ml

0.48

162

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.83

0.08

1.2

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

195

1.08

0.08

1.2

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

173

1700

1.02

0.07

1.8

1.7

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.02

0.07

1.3

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.02

0.07

1.3

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.12

0.07

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.89

0.06

1.9

2.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.87

0.06

1.6

1.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

104

0.86

0.06

1.4

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

237

1.06

0.05

1.2

1.1

—

(40768441) Liver Pathology biopsy report

1.11

0.05

1.4

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

485

0.97

0.05

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

484

0.97

0.04

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

484

0.97

0.04

1.5

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

564

0.97

0.04

1.6

1.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

142

1.06

0.02

1.3

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

197

0.96

0.01

4.6

3.6

19.11

27.51

u/ml

0.66

191

(3050129) First trimester maternal screen panel - Serum or Plasma

586

0.99

0.00

1.3

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

221

1.00

0.00

1.1

6.85

3.35

u/ml

0.26

(3017354) Segmented neutrophils/100 leukocytes in Blood

1.03

0.00

2.1

3.9

83.80

52.38

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

227

1.01

0.00

1.8

2.5

229.45

103.32

ug/min

0.43

137

(4281824)

125

1.04

0.00

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

105

1.05

0.00

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

(3014891) Appearance of Pleural fluid

0.00

0.0

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

0.90

0.00

1.3

2.1

—

2.07

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

2.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.99

0.00

1.8

1.7

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.99

0.00

1.0

2.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

4.3

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

20.97

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

2.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.0

1.0

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

7.17

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.6

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.0

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

0.00

0.0

1.0

—

0.83

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3006270) Folate [Moles/volume] in Blood

0.90

0.00

1.0

1.1

497.13

404.27

nmol/l

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.87

0.00

1.0

1.1

1628.83

1570.86

miu/ml

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3011544) Albumin [Mass/volume] in Pleural fluid

0.00

0.0

1.0

—

19.10

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.96

0.00

1.2

2.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3025315) Body weight

0.00

0.0

3.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.0

1.8

—

(3001729) Color of Synovial fluid

0.00

0.0

3.4

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

4.8

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.1

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

35.45

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_CLUSTHEADACHE_WIDE and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_CLUSTHEADACHE_WIDE	1.026 [0.85, 1.24]	0.79
Birth year	0.992 [0.98, 1.0]	0.085

During the follow-up period (1.1.1998 — 31.12.2019), 169 out of 3215 females with G6_CLUSTHEADACHE_WIDE died.

Males

Parameter	HR [95% CI]	p-value
G6_CLUSTHEADACHE_WIDE	1.249 [1.08, 1.44]	0.002
Birth year	0.988 [0.98, 1.0]	0.019

During the follow-up period (1.1.1998 — 31.12.2019), 339 out of 4187 males with G6_CLUSTHEADACHE_WIDE died.

Mortality risk

Mortality risk for people of age

years, who have G6_CLUSTHEADACHE_WIDE.

N-year risk	Females	Males
1	0.116%	0.231%
5	0.623%	1.271%
10	1.415%	3.425%
15	2.806%	6.856%
20	4.755%	11.961%

Relationships between endpoints

↥

Index endpoint: G6_CLUSTHEADACHE_WIDE – Cluster headache, wide

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Cluster headache, wide

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints